EurekaMag Full Text Articles Chapter 34,172

Anonymous 1997: V T Morozova. Klinicheskaya Laboratornaya Diagnostika 1997(2): 51

Dekker, D.Kiefte, P.A. 1994: V The Kenya Association for the Welfare of Epileptics. Tropical and Geographical Medicine 46(3 Suppl): S20-S21

Balashev, L.L.V.V. 1956: V V Dokuchaev and A N Engelhardt. Pochvovedenie 5: 93-97

Anonymous 1996: V V Rybalko. Problemy Tuberkuleza 1996(3): 62

Cooke, J.C.; Ferreira, R.N. 1990: V a mycorrhizae in a sand dune of eastern connecticut. Boletim da Sociedade Broteriana 63(2): 387-392

Inge, W.; Theil, D.; Fracica, P.J.; Exposito, A.; Wong, A.; Moon, R.E. 1989: V a q mismatching by multiple inert gas technique an early sign of hyperoxic damage in the baboon. Anesthesiology 71(3A): A1128

Natarajan, K.; Zauderer, M. 1992: V alpha 4 dominance in a non crossreactive mixed isotype a beta de alpha d restricted t cell response. Journal of Cellular Biochemistry Suppl (16 Part D): 37

Takahama, Y.; Singer, A. 1991: V beta 8 overexpression in cd4 negative cd8 negative tcr alpha beta positive thymocytes is not a consequence of self tolerance. Journal of Cellular Biochemistry Suppl (15 Part A): 239

Renz, H.; Kappler, J.; Marrack, P.; Gelfand, E.W. 1991: V beta 81 82 t cells are involved in in vivo and in vitro ige production in the mouse. FASEB Journal 5(4): A605

Grossman, D.; Van, M.; Rich, R.R. 1992: V beta analysis of mutant and chimeric staphylococcal enterotoxins. FASEB Journal 6(5): A1969

Birnbaum, G.; Lackovic, V.; Van Ness, B. 1991: V beta gene expression of t cells in the brain spinal fluid and blood of patients with ms and other neurologic diseases. Neurology 41(3 Suppl 1): 218

Terry, L.A.; Posnett, D.; Flomenberg, N. 1990: V beta gene segment usage in a subset of peripheral cd8 positive t cells. Human Immunology (ABSTR ED): 4

Leong, S.P.L.; Zhou, Y.M.; Granberry, M.E.; Wang, T.F.; Rittershaus, C.; Mehta, A.; Lin, A.Y. 1991: V beta t cell receptors are involved in the ctl recognition of autologous human melanoma following in vitro sensitization. Proceedings of the American Association for Cancer Research 32: 236

Carnaud, C.; Edouard, P.; Thivolet, C.; Bendelac, A.; Sarukhan, A.; Garchon, H.J.; Bach, J.F. 1991: V beta usage in the nod disease. Diabetes Research and Clinical Practice 14(Suppl 1): S20

Soloff, R.; Dempsey, D.; Jennings, S.R.; Wolcott, R.M.; Chervenak, R. 1991: V beta utilization by progeny of cultured precursor t pre t cells. FASEB Journal 5(6): A1701

Sell, S.M. 1992: V d j recombinase precursors and coding structure of signal sequences directed rearrangement. Computers and Chemistry 16(2): 125-133

Weaver, D.; Hendrickson, E. 1990: V d j recombination in scid lymphoid cells. FASEB Journal 4(7): A2324

Vincken, W.; Magder, S.; Ernst, P.; Cosio, M.G. 1992: V d v t and its response to exercise in patients with mitral valve disease. American Review of Respiratory Disease 145(4 Part 2): A585

Needleman, B.W.; Wigley, F.M.; Stair, R.W. 1991: V delta 1 plus gamma delta t cells in scleroderma. Arthritis and Rheumatism 34(9 Suppl): S57

Allmen, E.U.-v.; Koch, M.; Fritz, G.ün.; Legler, D.F. 2008: V domain of RAGE interacts with AGEs on prostate carcinoma cells. Prostate 68(7): 748-758

Damm, K.; Umesono, K.; Evans, R.M. 1989: V erb a functions as a thyroid hormone receptor antagonist. Journal of Cellular Biochemistry Suppl (13 Part C): 271

Zenke, M.; Disela, C.; Munoz, A.; Sap, J.; Vennstrom, B.; Beug, H. 1990: V erb a oncogene activation entails the loss of hormone dependent transactivator activity of c erb a. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 2): 941

Beug, H. 1989: V erb a oncogene function is the t 3 receptor converted into a constitutive repressor of erythrocyte genes. European Journal of Cell Biology Suppl (26): 82

Sharif, M.; Bonde, B.; Yamamoto, K.; Privalsky, M.L. 1991: V erb and c erb a action in yeast and in vertebrate cells. Journal of Cellular Biochemistry Suppl 15(Part E): 9

Wen, L.; Demaine, A.; Mowat, A.P.; Mieli Vergani, G.; Vergani, D. 1991: V gamma gene usage by t cell clones derived from liver biopsies of children with autoimmune liver disease. Hepatology 14(4 Part 2): 61A

Croitoru, K.; Bienenstock, J.; Ishida, I.; Ito, K.; Bonneville, M.; Tonegawa, S.; Ernst, P.B. 1989: V gamma t cell receptor gene rearrangement and expression in intraepithelial leukocyte subsets of cba j and c57bl 7 mice. Gastroenterology 96(5 Part 2): A102

Smithson, S.L.; Srivastava, N.; Westerink, M.A.J. 1998: V gene family usage in the anti-MCPS response in hu-PBL-SCID mice vs the in vivo anti-MCPS response. Abstracts of the General Meeting of the American Society for Microbiology 98: 238

Herzenberg, L.A.; Bhat, N.M.; Teng, N.N.H.; Kantor, A. 1991: V genes and antibody specificities expressed by cd5 b cells. Journal of Cellular Biochemistry Suppl (15 Part A): 220

Kasturi, K.N.; Sidman, C.L.; Bona, C.A. 1989: V genes encoding autoantibodies in me v mice. FASEB Journal 3(3): A493

Kasturi, K.N.; Bona, C.A. 1990: V genes encoding autoantibodies in motheaten mice. Journal of Cellular Biochemistry Suppl (14 Part D): 276

Daian, C.; Saitoh, Y.; Hall, B.; Bona, C.; Kasturi, K. 1992: V genes expression in autoantibodies produced by tight skin mice. FASEB Journal 6(5): A1794

Bridges, S.L.Jr; Lee, S.K.; Koopman, W.J.; Schroeder, H.W.Jr 1991: V h 1 gene segments expressed in rheumatoid synovium. Arthritis and Rheumatism 34(9 Suppl): S89

Friedman, D.F.; Goldman, J.; Silberstein, L.E. 1990: V h gene alterations during the evolution of a human b cell lymphoma with a conserved autoimmune specificity. Journal of Cellular Biochemistry Suppl (14 Part D): 275

Leeper, F.; Manz, J.; Storb, U.; Longo, D.; Kenny, J. 1989: V h gene expression in hybridomas from m167 u plus k transgenic mice. FASEB Journal 3(4): A1113

Berenson, J.; Cao, J.; Waldburger, K.; Lichtenstein, A.K. 1991: V h gene family usage in multiple myeloma. Proceedings of the American Association for Cancer Research 32: 271

Mcintyre, T.M.; Kurrasch, R.; Kastner, D.; Steinberg, A.D. 1989: V h gene usage of peritoneal cells by in situ hybridization. FASEB Journal 3(4): A1112

Chao, M.; Voss, E.W.Jr 1991: V h10 germline genes an autoimmune gene family. FASEB Journal 5(4): A646

Tsang, T.C.; Chu Y W.C.; Hendrix, M.J.C.; Bowden, G.T. 1992: V jun oncogene suppresses both the phorbol ester tpa induced tumor cell invasion and stromelysin expression. Proceedings of the American Association for Cancer Research 33: 396

Victor K.D.; Natvig J.B.; Fu S.M.; Capra J.D. 1990: V l gene usage of rheumatoid factors rf isolated from patients with autoimmune disorders are distinct from those encoding the wa po and bla cross reactive idiotypes cri. FASEB Journal 4(7): A2257

Skok, V.I. 1991: V like potential dependent acetylcholine activated membrane conductance. Biologicheskie Membrany 8(11): 1133-1134

Ness, S.; Introna, M.; Graf, T. 1990: V myb an oncogene which determines the differentiation phenotype of myeloid cells. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 2): 1064

Quarto, R.; Dozin, B.; Tacchetti, C.; Zenke, M.; Campanile, G.; Cancedda, R. 1990: V myc inhibits terminal differentiation of quail embryo chondrocytes. Cell Biology International Reports 14(ABSTR Suppl): 245

Iwamura, T.; Takeda, Y.; Nishimura, T. 1989: V myc like dna in chlorella characteristics and transcriptional changes during the cell cycle. Cell Structure and Function 14(6): 974

Aukburg, S.J.; Gobran, S.R.; Neufeld, G.R.; Scherer, P.W. 1990: V q distribution in a computer model of single acinar units. FASEB Journal 4(3): A421

Greenhalgh, D.A.; Rothnagel, J.A.; Quintanilla, M.I.; Bundman, D.; Longley, M.A.; Roop, D.R. 1992: V ras h a expression induces hyperplasia hyperkeratosis and delayed limited tumorigenesis when targeted to the epidermis of transgenic mice. Proceedings of the American Association for Cancer Research 33: 183

Garbi, C.; Feliciello, A.; Gallo, A.; Nitsch, L.; Avvedimento, E.V. 1991: V ras oncogene interferes with the nuclear transport of cyclic amp dependent protein kinase a. European Journal of Cell Biology Suppl (35): 36

Jackson B.; Ye X.J.; Marion T.N.; Terato K.; Tillman D.M.; Krug M.S.; Yoo T.J. 1992: V region cdna sequences of anti type ii collagen antibodies. Journal of Allergy and Clinical Immunology 89(1 Part 2): 255

Lee M.K.; Ye X.J.; Marion T.N.; Terato K.; Yoo T.J. 1991: V region complementary dna sequences of anti type ii collagen antibodies which induce polychondritis in mice. Journal of Allergy and Clinical Immunology 87(1 Part 2): 159

Y.X.J.; Marion, T.N.; Terato, K.; Tillman, D.M.; Yoo, T.J. 1990: V region complementary dna sequences of anti type ii collagen antibodies which induce relapsing polychondritis in mice. FASEB Journal 4(7): A2258

Bell, C.G. 1996: V region connectivity vs mimicry in the selection of T-cell repertoire. Biochemical Society Transactions 24(1): 97s

Wright, A.; Wallick, S.; Tao, M.H.; Kabat, E.A.; Morrison, S.L. 1992: V region glycosylation and antigen binding in monoclonal anti alpha 1 6 dextrans. Biochemical Society Transactions 20(2): 259

Bartels, J.H.; Dwyer, D.S. 1989: V region sequence analysis of antibodies from complementary the autoimmune response against the acetylcholine receptor using pcr amplified complementary dna. Journal of Cellular Biochemistry Suppl (13 Part E): 274

L.R.sa F.A.; Spicer, D.B.; Duyao, M.P.; Kessler, D.J.; Sonenshein, G.E. 1992: V rel inhibits murine c myc expression through nfkb elements. Journal of Cellular Biochemistry Suppl (16 Part F): 24

Golab, T.J.; Buas, M.; Lubs, H.A.; Ledley, R.S. 1989: V scan. American Journal of Human Genetics 45(4 Suppl): A277

Berger, E.S. 1989: V shaped ear ventilation tube us patent 4808171 february 28 1989. Official Gazette of the United States Patent and Trademark Office Patents 1099(4): 2066

D'amelio, F.D. 1997: V shaped grooved roller electrode for a resectoscope. Official Gazette of the United States Patent and Trademark Office Patents 1195(1): 274-275

Carpenter, P.C.; Oatley, S.C.; Mercola, M.; Mercola, D. 1990: V sis dependent tumor formation is reversible while subsequent tumor growth rapidly becomes irreversible. Journal of Cell Biology 111(5 Part 2): 99A

Yang, D.J.; Maher, V.M.; Mccormick, J.J. 1992: V sis oncogene induced transformation of human fibroblasts into cells capable of forming benign tumors. Proceedings of the American Association for Cancer Research 33: 80

Kinker, J.R.; Waugh, J.B. 1989: V slope determination of the anaerobic threshold with three minute work stages. Respiratory Care 34(11): 1019

Birchenall Roberts, M.C.; Kasper, J.; Ruscetti, F.W. 1990: V src gene products and serum regulate tgf beta 1 messenger rna transcription in the 32 d myeloid cell lines. Journal of Cellular Biochemistry Suppl (14 Part B): 152

Foster, D.A.; Song, J. 1991: V src induced increases in diacylglycerol derive from phosphatidylcholine via a type d phospholipase activity. Journal of Cellular Biochemistry Suppl (15 Part B): 153

Matte, T.D.; Baker, E.L.; Honchar, P.A. 1989: V the selection and definition of targeted work related conditions for surveillance under sensor. American Journal of Public Health 79(Suppl): 21-25

Shapiro, G.; Hintze, T.; Decholnoky, A.; Zeballos, G. 1989: V wave minute wall stress is the sensing mechanism responsible for anf secretion during acute changes in blood volume in conscious dogs. FASEB Journal 3(3): A384

Howl, J.; Wheatley, M. 1993: V-1a vasopressin receptors Selective biotinylated probes. Comparative Biochemistry and Physiology C Comparative Pharmacology and Toxicology 105(2): 247-250

Barberis, C.; Durroux, T.; Audigier, S.; Balestre, M.N.; Jard, S.; Manning, M.; Sawyer, W.H. 1993: V-1a vasopressin receptors Studies with radioiodinated ligand. Conn, P M Methods in Neurosciences; Neuropeptide analogs, conjugates, and fragments : 297-307

Roig, S.; Vinals, I.; Aldasoro, M.; Medina, P.; Vila, J.M.; Otero, E.; Lluch, S. 1996: V-2 receptor-mediated relaxation by desmopressin in human saphenous vein. Journal of Physiology (Cambridge) 493P: 79S

Putensen, C.; Rasanen, J.; Lopez, F. 1994: V-A/Q distributions improve during inhalation of nitric oxide in pigs with methacholine-induced bronchoconstriction. Anesthesiology 81(3A): A1441

Bowen, W.M.; Rivera, C.E.; Krauss, A.N.; Auld, P.A.M. 1993: V-A/Q relationships 0-120 minutes after surfactant. Pediatric Research 33(4 Part 2): 318A

Thrush, D.N.; Marath, A.; Mckeown, P.; Hodges, M.R.; Jackson, C.; Preece, P.; Smith, R.A. 1996: V-A/Q relationships and dead space after reduction pneumoplasty. Anesthesiology 85(3A): A1112

Owen Lynch, P.J.A.K.Y.W.ng; Whetton, A.D. 1994: V-ABL mediated haemopoietic cell survival is associated with differential association of SHC with ABL without concomitant mapkinase activation. Experimental Hematology 22(8): 833

Wilkins, T.A.; Wang, C.Y. 1994: V-ATPase subunit organization and polyploid speciation in cotton. American Journal of Botany 81(6 Suppl): 78-79

Glassman, R.H.; Hempstead, B.L.; Hanafusa, H.; Birge, R.B. 1996: V-CRK, an effector of the nerve growth factor signaling pathway, delays apoptotic cell death in neurotrophin-deprived PC12 cells. Biochemical Society Transactions 24(4): 573S

Anderson, D.H. 1994: V-FPS constitutively associates with the PDGF receptor and induces receptor protein down regulation. Journal of Cellular Biochemistry Suppl 1994(18B): 231

Suzuki Jaecks, I.; Glas, A.M.; Pfister, L.; Nottenburg, C.; Milner, F.C.B. 1993: V-H contribution to the human antibody repertoire. Journal of Immunology 150(8 Part 2): 152A

Silverman, G.J.; Bouvet, J.P.; Roben, P. 1995: V-H framework-specific interactions of a human B cell antigen receptor superantigen. FASEB Journal 9(3): A496

Varade, W.; Marin, E.; Milano, M.; Insel, R.; Swerdlow, S.; Williams, M. 1995: VH gene repertoire of mantle cell lymphomas. Annals of the new York Academy of Sciences 764: 504-506

Boonthum, A.; Knight, K.L. 1996: V-H gene usage in V-H-alpha-2 allotype-producing B cells from mutant Alicia rabbits. FASEB Journal 10(6): A1173

Boonthum, A.; Knight, K.L. 1995: V-H gene usage in V-Ha2 allotype-producing B cells from mutant Alicia rabbits. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 506

Rettig, M.B.; Vescio, R.A.; Cao, J.; Wu, C.H.; Lee, J.C.; Han, E.; Derdanielian, M.; Liechtenstein, A.K.; Berenson, J.R. 1995: V-H gene usage in multiple myeloma Complete absence of the V-H421 gene. Blood 86(10 Suppl 1): 60A

Ng, V.L.; Hurt, M.H.; Herndier, B.G.; McGrath, M.S. 1995: VH gene use by CD5+ AIDS-associated B-cell lymphoproliferations. Annals of the new York Academy of Sciences 764: 507-508

Singh, R.R.; Ebling, F.B.; Sercarz, E.E.; Hahn, B.H. 1995: V-H region determinants from autoantibodies to DNA play a role in pathogenesis of murine lupus. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 401

Marshall, A.J.; Paige, C.J.; Wu, G.E. 1997: V-H repertoire maturation during B cell development in vitro Fetal and adult B cell progenitors have different selection mechanisms. Journal of Allergy and Clinical Immunology 99(1 Part 2): S247

Tresguerres, M.; Parks, S.K.; Goss, G.G. 2006: V-H(+)-ATPase, Na(+)/K(+)-ATPase and NHE2 immunoreactivity in the gill epithelium of the Pacific hagfish (Epatretus stoutii). Comparative Biochemistry and Physiology. Part A Molecular and Integrative Physiology 145(3): 312-321

Ye, J.; Mccray, S.K.; Clarke, S.H. 1995: V-H12-expressing pre-B cells are ligand-selected based on their V-HCDR3 structures. Journal of Cellular Biochemistry Suppl 1995(21A): 134

Dong, S.; Huang, W.; Tong, J.; Wang, Z.; Chen, S.; Chen, Z.; Gu, L.; Li, X.; Xie, J. 1995: V-J junctional sequences of T cell receptor gamma gene in acute lymphocytic leukemia. Science in China. Series B Chemistry Life Sciences and Earth Sciences 38(2): 202-210

Yamamura, Y.; Noda, M.; Ikawa, Y. 1993: V-K-ras complement erythropoietin signaling in an erythropoietin receptor-introduced T cell line. Lymphokine and Cytokine Research 12(5): 354

Kwon, S.W.; Shim, B.S.; Choi, H.R.; Jang, S.H. 1997: V-LAP and ILC. Journal of Endourology 11(Suppl 1): S70

Knopfova, L.; Smarda, J. 2008: v-Myb suppresses phorbol ester- and modifies retinoic acid-induced differentiation of human promonocytic U937 cells. Neoplasma 55(4): 286-293

Billat, V.; Richard, R.; Petit, B.; Koralsztein, J.P. 1996: V-O2 drift at supra-lactate threshold exercise performed to exhaustion does not lead to V-O2max depends on type of exercise. Archives of Physiology and Biochemistry 104(4): D71-D72

Fujii, M.; Minamino, T.; Nomura, M.; Miyamoto, K.; Tanaka, J.; Seiki, M. 1997: V-Rel activates the proto-oncogene c-Jun promoter: a correlation with its transforming activity. Leukemia 11(Suppl 3): 402-404

Kasahara, K.; Nakayama, Y.; Yamaguchi, N. 2008: V-Src and c-Src, nonpalmitoylated Src-family kinases, induce perinuclear accumulation of lysosomes through Rab7 in a kinase activity-independent manner. Cancer Letters 262(1): 19-27

Foster, D.A.; Alexandropoulos, K.; Qureshi, S.A.; Jiang, H.; Song, J. 1993: V-Src-induced intracellular signaling involves at least three distinct GTPase-dependent steps. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 252

Danial, N.; Pernis, A.; Rothman, P. 1995: V-abl Induced Jak-STAT signaling. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 312

Koseki, H.; Makino, Y.; Adachi, Y.; Taniguchi, M. 1992: V-alpha-14 T-cell antigen receptor repertoire and its function. International Archives of Allergy and Immunology 99(2-4): 416-418

Prussin, C.; Foster, B. 1997: V-alpha-24+, V-beta-11+ natural T cells are the human analog of murine NK11 T cells and demonstrate a predominant Th1 phenotype. Journal of Allergy and Clinical Immunology 99(1 Part 2): S257

Araki, Y.; Gonzalez, E.L. 1998: V-and P-type Ca2+-stimulated ATPases in a calcifying strain of Pleurochrysis Sp. Journal of Phycology 34(1): 79-88

Kurt, R.A.; Park, I.A.; Schluter, S.F.; Marchalonis, I.I.; Akporiaye, E.T. 1995: V-beta T cell receptor and cytokine analysis of three murine tumors undergoing rejection. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 879

Jiang, H.; Ware, R.; Stall, A.; Flaherty, L.; Chess, L.; Pernis, B. 1995: V-beta TCR specific CD8+ T cells that delete CD4+ cells expressing V-beta-8 TCR The role of QA-1. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY The 9th International Congress of Immunology : 181

Zella, D.; Cara, A.; Secchiero, P.; Sottini, A.; Imberti, L.; Lusso, P.; Primi, D.; Reitz, M. 1994: V-beta chain repertoire analysis during in vitro infection by T-lymphotropic viruses. AIDS Research and Human Retroviruses 10(Suppl 3): S95

Buenafe, A.C.; Vainiene, M.; Celnik, B.; Weinberg, A.D.; Vandenbark, A.A.; Offner, H. 1993: V-beta expression in spinal cord and CSF of Lewis rats during the course of experimental autoimmune encephalomyelitis. Journal of Immunology 150(8 Part 2): 161A

Mcginnis, D.E.; Thomas, R.; Lipsky, P.E.; Jenkins, R.N. 1994: V-beta gene bias in CD4+ and CD8+ T cells in normal donors and rheumatoid arthritis patients. Arthritis and Rheumatism 37(9 Suppl): S278

Deepe, G.S.; Cain, J.A.; Gomez, F.J. 1997: V-beta repertoire in mice infected with Histoplasma capsulatum. Abstracts of the General Meeting of the American Society for Microbiology 97: 276

Eiraku, N.; Hingorani, R.; Gregersen, P.K.; Ijichi, S.; Machigashira, K.; Ikegami, M.; Osame, M.; Hall, W.W. 1995: V-beta repertoire in peripheral blood T lymphocytes in HTLV-I infections. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(2): 245

Akolkar, P.N.; Gulwani Akolkar, B.; Hall, W.W.; Silver, J. 1994: V-beta specific activation of T cells by HTLV II and HTLV III. Clinical Research 42(2): 156A

Posnett, D.N.; Kabak, S.; Hodtsev, A.S.; Goldberg, E.A.; Asch, A. 1993: V-beta subsets are not preferentially deleted in AIDS. Clinical Research 41(2): 244A

Lorenzo, C.; Balderas, R.S.; Akin, E.; Paimela, L.; Torigoe, D.; Combitichi, D.; Theofilopoulos, A.N.; Trentham, D.E. 1993: V-beta usage by T cells in collagen-induced arthritis. Arthritis and Rheumatism 36(9 Suppl): S83

Nakao, S.; Zeng, W.H.; Takamatsu, H.; Takami, A.; Kondo, Y.; Miura, Y.; Yamazaki, H.; Chuhjo, T.; Shiobara, S.; Yoshioka, T.; Kaneshige, T.; Matsuda, T. 1996: V-beta-15+ T-cells with a similar clonotype dominantly proliferate in the bone marrow of aplastic anemia patients with HLA-DRB1*1501 responsive to cyclosporine therapy. Blood 88(10 Suppl 1 Part 1-2): 647A

Douillard, P.; Pannetier, C.; Joseien, R.; Menoret, S.; Kourilsky, P.; Soulillou, J.P.; Cuturi, M.C. 1996: V-beta-18-D-beta-1-J-beta-27 T-cell clonality in graft infiltrating cells in donor specific transfusion-induced allograft tolerance. Human Immunology 47(1-2): 107

Dadaglio, G.; Garcia, S.; Garcia, F.; Montagnier, L.; Gougeon, M.L. 1993: V-beta-8 specific anergy in T cells from asymptomatic HIV-infected individuals is not associated with an abnormal representation of the V-beta-8 T cell subset. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 203

Buenafe, A.C.; Vainiene, M.; Celnik, B.; Vandenbark, A.A.; Offner, H. 1994: V-beta-8-CDR3 sequences from CNS of Lewis rats with EAE. FASEB Journal 8(4-5): A245

Eide, D.M.; Bogen, B. 1992: V-beta-82 positive CD8 positive cells are positively selected by the K-d MHC class I molecule. Scandinavian Journal of Immunology 36(4): 625

Akolkar, P.N.; Gulwani Akolkar, B.; Chirmule, N.; Kalyanaraman, V.S.; Pahwa, S.; Macphail, S.; Silver, J. 1994: V-beta-Specific activation of T cells by the HIV glycoprotein gp160. AIDS Research and Human Retroviruses 10(Suppl 1): S64

Horneff, G.; Hanson, M.; Wahn, V. 1993: V-beta-chain repertoire and T-cell autoreactivity in juvenile rheumatoid arthritis. Journal of Rheumatology 20(Suppl 37): 57

Akolkar, P.N.; Gulwani Akolkar, B.; Silver, J. 1995: V-beta-specific activation of T cells by GP160/120 from different HIV strains. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 571

Gulwani Akolkar, B.; Akolkar, P.N.; Mckinley, M.; Silver, J. 1995: V-beta-specific alteration of the CD4+ TCR repertoire in Crohns disease. 9th International Congress Of Immunology. The 9th International Congress Of Immunology: 631

Gulwani Akolkar, B.; Akolkar, P.N.; Lin, X.; Silver, J. 1994: V-beta-specific changes in the T cell receptor repertoire of CD4+ lamina propria lymphocytes in CD. Gastroenterology 106(4 Suppl): A695

Rink, L.; Nicklas, W.; Alvarez Ossorio, L.; Koester, M.; Kirchner, H. 1993: V-beta-specific stimulation of T-cells by the Mycoplasma arthritidis-derived superantigen is dependent on the MHC class-II haplotype. Immunobiology 189(1-2): 186

Soudeyns, H.; Pantaleo, G.P.; Boghossian, T.; Ciurli, C.; Rebai, N.; Lane, H.C.; Fauci, A.S.; Sekaly, R.P. 1993: V-beta-specific variations in the T cell receptor repertoire of HIV-infected subjects suggest the presence of an HIV-associated superantigen. Journal of Cellular Biochemistry Suppl 1993(17 Part E): 71

Soudeyns, H.; Pantaleo, G.P.; Boghossian, T.; Ciurli, C.; Rebai, N.; Lane, H.C.; Fauci, A.S.; Sekaly, R.P. 1993: V-beta-specific variations in the TCR repertoire of HIV-infected subjects suggest the presence of an HIV-associated superantigen. Journal of Immunology 150(8 Part 2): 104A

Cochet, M.; Dadaglio, G.; Boullier, S.; Crouvoisier, M.; Montagnier, L.; Gougeon, M.L.se 1993: V-delta repertoire of gamma-delta-T cells in peripheral lymphocytes during HIV-infection Cellular and molecular characterization of delta-TCS1-positive T cells. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 199

D.R.sa, S.C.; Mitra, D.; Herzenberg, L.A.; Herzenberg, L.A.; Roederer, M. 1997: V-delta-1 and V-delta-2 gamma-delta T cells are phenotypically distinct subsets both in HIV-infected and uninfected individuals. Journal of Allergy and Clinical Immunology 99(1 Part 2): S296

Hinz, T.; Wesch, D.; Reckziegel, A.; Kriese, K.; Arden, B.; Kabelitz, D. 1994: V-delta-1-J-delta-1 junctional repertoire in HIV-1 infected and healthy donors. Immunobiology 191(2-3): 80-81

Orsini, D.L.M.; Res, P.C.M.; Van Laar, J.M.; Soprano, L.M.M.ller Alessandra, E.L.; Kooy, Y.M.C.; Breedveld, F.C.; Koning, F. 1992: V-delta-1-positive T cells from inflammatory arthritis patients proliferate to autologous and allogeneic B cells. Arthritis and Rheumatism 35(9 Suppl): S129

Palmisano, G.; Papaioannou, M.; Yaxley, J.C.; Hoffbrand, A.V.; Foroni, L. 1997: V-delta-2/D-delta-3 gene rearrangement in acute lymphoblastic leukaemia Incidence and molecular features. British Journal of Haematology 97(Suppl 1): 53

Nagl, S.B.; Allison, L.A. 1993: V-erb A causes germinal vesicle breakdown in Xenopus oocytes. Molecular Biology of the Cell 4(Suppl ): 352A

Harbers, M.; Wahlstrom, G.; Vennstrom, B. 1994: V-erbA can act through heterodimerisation with RXR. Journal of Cellular Biochemistry Suppl 1994(18B): 366

Miyauchi, M.; Fkushima, T.; Maruyama, K. 1996: V-fes Sequences in sarcomas induced with feline sarcoma virus in rats. Journal of Investigative Medicine 44(3): 198A

Kalataradi, H.; Zahradka, E.; Eyster, C.; O'brien, R.; Born, W. 1995: V-gamma-1V-delta-6 gamma-delta T cell subset in MHC class 1 deficient mice. Journal of Cellular Biochemistry Suppl 1995(21A): 121

Landau, S.B.; Aziz, W.I.; Woodcock Mitchell, J.; Melamede, R. 1995: V-gamma-2,3,4, and 8 are expressed by human gamma-delta intestinal lymphocytes. Gastroenterology 108(4 Suppl): A856

Reardon, C.L.; Zekman, T.; Born, W.K.; O'brien, R.L. 1996: V-gamma-5-TCRs of murine mammary T cells are distinct from V-gamma-5-TCRs of epidermal T cells. Journal of Investigative Dermatology 106(4): 879

Schoel, B.; Sprenger, S.; Kaufmann, S.H.E. 1994: V-gamma-V-delta-2T cells are stimulated by phosphate-containing mycobacterial compounds. Immunobiology 191(2-3): 88

Thompson, K.M.; Børretzen, M.; Randen, I.; Førre, O.; Natvig, J.B. 1995: V-gene repertoire and hypermutation of rheumatoid factors produced in rheumatoid synovial inflammation and immunized healthy donors. Annals of the new York Academy of Sciences 764: 440-449

Natvig, J.B.; Quayle, A.J. 1995: V-genes of T-cell receptors in rheumatoid arthritis. Annals of the new York Academy of Sciences 756: 138-146

Cannell, P.K.; Amlot, P.; Attard, M.; Hoffbrand, A.V.; Foroni, L. 1993: V-kappa gene usage in human B cells by sequence analysis of rearranged genes A comparative study between leukaemic and normal cells. Blood 82(10 Suppl 1): 522A

Bridges, S., L.J.; Lee, S.; Kon; Lavelle, J.; Johnson, M., L.; Koopman, W., J.; Schroeder, H., W.Jr 1993: V-kappa transcripts from synovium and peripheral blood lymphocytes of patients with longstanding rheumatoid arthritis demonstrate enhanced N region addition and CDR3 length variation. Arthritis and Rheumatism 36(9 Suppl): S126

Galin, F.S.; Maier, C.C.; Zhou, S.R.; Blalock, J.N.W. And, J.E. 1994: V-lambda-x-bearing monoclonal antibodies bind myelin basic protein. Journal of Neuroimmunology 54(1-2): 197

Bot, A.; Nangpal, A.; Pricop, L.; Bogen, B.; Kaushik, A.; Bona, C.A. 1997: V-light chain genes reconstitute immune responses to defined carbohydrate antigens or haptens by utilizing different V-H genes. Molecular Immunology 33(17-18): 1359-1368

Nathan, A.; Barbosa, V.C. 2008: V-like formations in flocks of artificial birds. Artificial Life 14(2): 179-188

Dolnikov, A.; Yi, S.; Millington, M.; Mackenzie, K.; Symonds, G. 1996: V-myc induced apoptosis in leukemogenesis. Proceedings of the American Association for Cancer Research 37: 568

Kodaki, T.; Woscholski, R.; Parker, P.J. 1995: V-Ras activates phosphatidylinositol 3-kinase. Biochemical Society Transactions 23(2): 195s

Glick, A.B.; Morgan, D.; Yuspa, S.H. 1996: V-ras-Ha initiated TGF-beta-1 null primary keratinocytes have an increased frequency of malignant conversion in vitro. Proceedings of the American Association for Cancer Research 37: 545

Pewzner, Y.; Simon, T.; Rajewsky, K.; Eilat, D. 1995: V-region genetic elements controlling anti-DNA affinity and their use as second generation immunoglobulin transgenes. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 624

Arala Chaves, M.; D'imperio Lima, M.R.; Coutinho, A.; Pena Rossi, C.; Minoprio, P. 1993: V-region-related and-unrelated immunosuppression accompanying infections. Memorias do Instituto Oswaldo Cruz 87(Suppl 5): 35-41

Morgan, J.C.; Majors, J.E.; Galileo, D.S. 1995: V-scr expression alters the proliferation and migration of neuroblasts in the developing chicken brain. Society for Neuroscience Abstracts 21(1-3): 30

Gerst, J.E.; David, D. 1995: V-snare bypass mutants of the late secretory pathway in yeast. Molecular Biology of the Cell 6(Suppl ): 396A

David, D.; Sundarababu, S.; Lustgarten, V.; Gerst, J.E. 1997: V-snare-independent exocytosis Selective coupling of alternative paths to the cell surface in yeast. Molecular Biology of the Cell 8(Suppl ): 193A

Taylor, R.L.Jr; Halpern, M.S. 1994: V-src DNA tumor metastasis in 6B congenic chickens. Poultry Science 73(Suppl 1): 43

Yanai, N.; Koguma, M.; Shimizu, A.; Obinata, M. 1993: V-src interferes with the ability of the spleen stromal cells to stimulate erythropoiesis in vitro. Cell Structure and Function 18(6): 631

Rondon, E.O.O.iedo; Murakami, A.E.; Moraes, E.R.G.rcia De; Oliveira, P.B.D.; Furlan, A.C. 1998: V-src sodium nutritional requirement of Japanese quail. Poultry Science 77(Suppl 1): 88

Gupta, R.W.; Joseph, C.K.; Foster, D.A. 1993: V-src transformation of mouse fibroblasts is reversed by okadaic acid. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 253

Gelman, I.H. 1993: V-src-Encoded tumor regression antigens. Proceedings of the American Association for Cancer Research 34: 459

Smith, M.J. 1995: V-v/vIII metabolism in ascidian homeostasis. Journal of Cellular Biochemistry Suppl 1995(21A): 262

Lowe, V.I.; Bullard, G.; Coleman, R.E. 1993: V/Q lung scan probability category distribution in university and community hospitals. Journal of Nuclear Medicine 34(5 Suppl): 17P

Luchetti, J.M.; Matsuda, L.S.; Claybaugh, J.R.; Uyehara, C.F.T. 1994: V1 blockade of endogenous vasopressin during hypoxia exacerbates pulmonary hypertension in the neonatal piglet. FASEB Journal 8(4-5): A587

Gutierrez, C.; Cusick, C.G. 1995: V1 connections reveal multiple visuotopic representations correlating with chemoarchitectonic subdivisions of the macaque inferior pulvinar. Society for Neuroscience Abstracts 21(1-3): 394

Trinh Trang Tan, M.M.; Promeneur, D.; Bankir, L. 1997: V1 effects markedly attenuate V2 effects of AVP on urea transporter mRNA level in thin descending limb and initial inner medullary collecting duct. FASEB Journal 11(3): A24

Yuan, B.; Uyehara, C.F.T.; Nakamura, K.T.; Claybaugh, J.R. 1998: V1 inhibition reduces sensitivity to Ach-induced aortic ring relaxation in SHR but not WKY rats Role for vascular vasopressin?. FASEB Journal 12(4): A385

O'keefe, L.P.; Movshon, J.A. 1995: V1 neuronal responses to 1st- and 2nd-order motion. IOVS Investigative Ophthalmology and Visual Science 36(4): S872

Qian, N.; Andersen, R.; Adelson, E. 1991: V1 responses to two surface transparent and non transparent motion. Society for Neuroscience Abstracts 17(1-2): 177

Lyons, M.J.; Kamachi, M.; Tran, P.; Gyoba, J.; Akamatsu, S. 1997: V1 similarity measure recovers dimensions of facial expression perception. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S1002

Chen, Long; El Sherif, Nabil; Mochly Rosen, Daria; Boutjdir, Mohamed 1998: V1-Region-derived peptide of epsilonPKC and C2-region-derived peptide of alphaPKC regulate cardiac Ca channels. Circulation 98(17): I233

Tyska, M.J.; Hayes, E.; Giewat, M.; Seidman, C.E.; Seidman, J.G.; Warshaw, D.M. 1998: V1-cardiac myosin isolated from a mouse model of FHC moves actin slower and has altered unitary mechanics. Biophysical Journal 74(2 Part 2): A121

Bernroider, G.; Leutgeb, S. 1994: V1-receptor mediated effects of vasotocin on motivational, mnemonic and aversive components of sexual learning in quail. Society for Neuroscience Abstracts 20(1-2): 1602

Islam, M.Z.; Williams, B.C.; Madhavan, K.K.; Hayes, P.C.; Hadoke, P.W.F. 1998: V1-receptors mediate the contractile response to arginine vasopressin in hepatic arteries from patients with and without cirrhosis. British Journal of Pharmacology 125(Proceedings Suppl ): 102P

Alvisi, M.; De Arcangelis, V.; Ciccone, L.; Palombi, V.; Alessandrini, M.; Nemoz, G.; Molinaro, M.; Adamo, S.; Naro, F. 2008: V1a vasopressin receptor expression is modulated during myogenic differentiation. Differentiation; Research in Biological Diversity 76(4): 371-380

Yamazaki, R.S.; Chen, Q.; Schreiber, S.; Brinton, R.D. 1995: V1a vasopressin receptor gene expression in cultured cortical neurons, astrocytes and oligodendrocytes. Society for Neuroscience Abstracts 21(1-3): 1843

Gouzenes, L.; Sabatier, N.; Richard, P.; Moos, F.; Dayanithi, G. 1998: V1a- and V2-vasopressin receptor agonist-induced i responses in vasopressin-sensitive neurones of the rat supraoptic nucleus. Journal of Physiology (Cambridge) 509P: 86P-87P

Wildin, R.S.; Bennett, R.L.; Schoof, J.M.; Scott, C.R.nald 1993: V2 antidiuretic hormone receptor gene mutations in congenital X-linked nephrogenic diabetes insipidus. Pediatric Research 33(4 Part 2): 135A

Shioda, T.; Oka, S.; Xin, X.; Liu, H.; Harukuni, R.; Fukushima, M.; Kurotani, A.; Hasan, M.K.; Toriyoshi, H.; Iwamoto, A.; Nagai, Y. 1996: V2 extension of HIV-1 is associated with slow/moderate disease progression. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol One One world: One hope : 276-277

Padberg, J.; Xiao, Y.; Cusick, C.G.; Felleman, D.J. 1998: V2 thin stripe and interstripe projections to inferior pulvinar complex. Society for Neuroscience Abstracts 24(1-2): 1393

Wildin, R.S. 1996: V2 vasopressin receptor mutation Y205C causing nephrogenic diabetes insipidus retains partial function in vitro. Journal of Investigative Medicine 44(1): 64A

Weitz, J.I.; Hanson, S.R.; Anderson, J.A.; Guo, S.; Ghazarossian, V.; Hirsh, J. 1998: V20, a glycoprotein IIb/IIIa-independent inhibitor of platelet-dependent clotting reactions, inhibits both arterial and venous-type thrombosis in primates. Circulation 98(17): I800

Hattori, T.; Xu, Y.; Murakami, T.; S.Kawase; Uchiyama, T. 1995: V3 Loop Binding Protein from U937 cells Are Similar to that of Molt-4 cells. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 824

Hattori, T.; Kawase, S.; Murakami, T.; Uchiyama, T. 1994: V3 binding proteins of U937 cells. Journal of Cellular Biochemistry Suppl 1994(18B): 119

Mammano F.F. Salvatori; Ometto, L.; Panozzo, M.; Chieco Bianchi, L.; De Rossi, A. 1994: V3 loop and phenotype of HIV-1 isolates from children with perinatally acquired HIV-1 infection. AIDS Research and Human Retroviruses 10(Suppl 3): S91

Hattori, T.; Murakami, T.; Uchiyama, T. 1993: V3 loop binding protein from cellular membrane fractions of Molt-4 cells. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 17

Garaev, M.M.; Cheingsong Popov, R.; Bobkov, A.; Rzhaninova, A.; Pitman, R.; Weber, J. 1993: V3 loop diversity in the cohort of patients with multiple transmissions of HIV-1 presumably originating from the same source. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 165

Nehete, P.N.; Arlinghaus, R.B.; Sastry, K.J.gannadha 1994: V3 loop synthetic peptides block infection and syncytium formation by HIV-1. Norrby, E, Brown, F, Chanock, R M, Ginsberg, H S Vaccines (Cold Spring Harbor); Modern approaches to new vaccines including prevention of AIDS 285-289

Fantini, J.; Yahi, N.; Mabrouk, K.; Rochat, H.; Van Rietschoten, J.; Sabatier, J.M.rc 1996: V3 loop-derived multibranched peptides as inhibitors of HIV infection in CD4+ and CD4- cells. Perspectives in Drug Discovery and Design 5: 243-250

Orloff, G.M.; Kalish, M.L.; Chiphangwi, J.; Potts, K.E.; Ou, C.Y.; Schochetman, G.; Dallabetta, G.; Saah, A.I.; Miotti, P.G. 1993: V3 loops of HIV-1 specimens from pregnant women in Malawi uniformly lack a potential N-linked glycosylation site. Aids Research and Human Retroviruses 9(7): 705-706

Menendez, A.; Montero, M.; Quintana, D.; Gomez, C.; Navea, L.; Vilarubia, O.; Carpio, E.; Hayes, O.; Duarte, C. 1996: V3 multi-epitope polypeptides The number of V3 regions affects the exposition of epitopes and the immunogenicity. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Eleventh International Conference on AIDS, Vol One One world: One hope : 282

Buonaguro, F.M.; Buonaguro, L.; Del Gaudio, E.; Tornesello, M.L.; Monaco, M.; Greco, D.; Corti, P.; Teasdale Corti, L.; Beth Giraldo, E.; Giraldo, G.; Program, I.U. Cooperation Aids 1996: V3 region genotyping of HIV isolates in northern Uganda Heteroduplex mobility assay, nucleotide sequence and phylogenetic analysis. Giraldo, G , Bolognesi, D P , Salvatore, M , Beth-Giraldo, E Antibiotics and Chemotherapy (Basel); Development and applications of vaccines and gene therapy in AIDS 39-48

Chiodi, F.; Keys, B.; Fadell, B.; Karis, J. 1992: V3 sequence analysis of hiv 1 isolates from blood and csf indicates markers for disease progression but does not identify tissue specific determinants. Journal of Cellular Biochemistry Suppl (16 Part E): 46

Morgado, M.G.; Sabino, E.; Bongertz, V.; Brigido, L.; Galvo Castro, B.; Hendry, M.; Mayer, A. 1993: V3 sequence diversity among Brazilian HIV-1 samples. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 163

Gudino, J.C.; Basualdo, M.C.; Soler, C. 1993: V3 sequence variants and viral selection in cultured HIV Mexican isolates. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 158

Ursula, D.; Ruppach, H.; Gehring, S.; Maayan, S.; Soriano, V.; Knechten, H.; Jaeger, H.; Ruebsamen Waigmann, H. 1996: V3-Based PEIA for serodifferentiation in HIV types and subtypes Non-B HIV-I subtypes contributes to the epidemic in Germany, Spain and Israel. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Eleventh International Conference on AIDS, Vol One One world: One hope : 217

Collman, R.; Srinivasan, A.; Kim, F. 1995: V3-Independent Determinants of Macrophage Tropism in a Primary HIV-1 Isolate. AMERICAN SOCIETY FOR MICROBIOLOGY Author Human retroviruses and related infections : 64

Javaherian, K.; Khiroya, R.; Quinlan, C.; Boyd, J.G.; Hanham, K.A. 1994: V3-mediated heparin neutralization of HIV type 1. Aids Research and Human Retroviruses 10(11): 1421-1423

Montefiori, D.C.; Zhou, J.; Bucco, R.; Zhou, J.; Cavacini, L.; Posner, M.R. 1993: V3-specific neutralizing antibodies in sera from HIV-1 GP160-immunized volunteers block virus attachment and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding region of GP120. AIDS Research and Human Retroviruses 9(Suppl 1): S79

Merigan, W.H.; Pham, H.A. 1996: V4 lesions produce permanent, retinotopic defects on certain types of pattern discriminations. IOVS Investigative Ophthalmology and Visual Science 37(3): S486

Logothetis, N.K.; Charles, E.R. 1990: V4 responses to gratings defined by random dot motion. IOVS Investigative Ophthalmology and Visual Science 31(4): 90

Hegele, R.A.; Tully, C.; Young, T.K.; Connelly, P.W. 1997: V677 mutation of methylenetetrahydrofolate reductases and cardiovascular disease in Canadian Inuit. Lancet 349(9060): 1221-1222

Rivas, A.; Ruegg, C.L.; Laus, R.; Madani, N.D.; Zeitung, J.; Benike, C.; Engleman, E.G. 1995: V7, a new member of the Ig superfamily that plays a role in T cell activation. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 221

Naikai, H. 1989: V79 al162 s 10. PNE (Protein Nucleic Acid and Enzyme) 34(11): 1395-1396

Bhuyan, B.K.; Smith, K.S.; Sampson, K.E.; Abraham, I. 1991: V79 cells resistant to the alkylating agent u 73975 are multidrug resistant. Proceedings of the American Association for Cancer Research 32: 367

Doehmer, J.; Oesch, F. 1991: V79 Chinese hamster cells genetically engineered for stable expression of cytochromes P450. Methods in Enzymology 206: 117-123

Zukowski, D.; Staab, A.; Scholz, M.; Kraft, G.; Mueller Klieser, W. 1997: V79 spheroids as a model to study the radiobiological characteristics of heavy charged particles under tissue-like conditions. European Journal of Cell Biology 74(Suppl 47): 65

Cerovsky, V. 1991: V8 proteinase catalyzed peptide synthesis in hydrophilic organic solvents with low water content. Tetrahedron Letters 32(28): 3421-3424

Hayden, E.; Roberts, L.M.; Brouillette, C.G. 1994: V8 proteolysis of reconstituted HDL particles A conformational analysis. Biophysical Journal 66(2 Part 2): A402

Scott, S.M.; Deupree, R.H.; Sharma, G.V.R.K.; Luchi, R.J.; Angina, T.A.sociates O.T.e V.C.operative Study, O.U.stable 1994: VA Cooperative Study of unstable angina 10-year results. Circulation 90(4 Part 2): I639

Mridha, M.A.U.; Mitra, M.; Parveen, Z. 1992: VA and Rhizobium interaction in productivity and nutrient content of yard long bean. Read, D J, Lewis, D H, Fitter, A H, Alexander, I J Mycorrhizas in ecosystems: 393

Colwell, J.; Abraira, C.; Henderson, W.; Emanuels, N.; Levin, S.; Nuttal, F.; Sawin, C.; Comstock, J.; Pacold, I. 1996: VA cooperative study on glycemic control and complications in type II diabetes Micro and macrovascular events. Diabetologia 39(Suppl 1): A34

Cui, M.; Caldwell, M.M. 1995: VA mycorrhizae and plant acquisition of nitrate and phosphorus when in uniform and patchy distributions. Bulletin of the Ecological Society of America 76(2 Suppl Part 2): 57

DeepakVyas; Singh,P.K.; Mishra,M.K.; ArchanaDubey 2008: VA mycorrhizal association in weeds of seminatural grassland of Sagar. Indian Journal Of Agroforestry: 2, 91-97

Weissenhorn, I.; Leyval, C.; Berthelin, J. 1992: VA mycorrhizal colonization of maize in an industrially polluted soil and heavy metal transfer to the plant. Read, D J, Lewis, D H, Fitter, A H, Alexander, I J Mycorrhizas in ecosystems: 409

Mottethadka, V.M.; Wallace, L.L. 1995: VA mycorrhizal feedbacks of plant form and function in two physiologically different grasses Agropyron caninum and Sporobolus pyramidalis. Bulletin of the Ecological Society of America 76(3 Suppl): 368

Wright, D.P.; Scholes, J.D.; Read, D.J. 1998: VA mycorrhizal sink strength influences the carbon allocation of Trifolium repens L. Journal of Experimental Botany 49(Suppl ): 60

DeepakVyas 2008: VA mycorrhizal status in wheat cultivar 306 under different phosphorus concentration. Indian Journal Of Agroforestry: 1, 62-64

Scott, S.M.; Deupree, R.H.; Sharma, G.V.R.K.; Luchi, R.J. 1993: VA study of unstable angina-10-year results show duration of surgical advantage for patients with impaired ejection fraction. Circulation 88(4 Part 2): I636

Uchiyama Tsuyuki, Y.; Araki, H.; Okuyama, S.; Kawashima, K.; Otomo, S. 1993: VA-045 protects against hypoxia-induced neuronal injury in rat cortical culture. Japanese Journal of Pharmacology 61(Suppl 1): 288P

Del Rio, J.; Artaiz, I.; Zazpe, A.; Romero, G.; Monge, A.; Roca, J.; Lasheras, B. 1993: VA-21B7 An atypical 5-hydroxytryptaminergic anxiolytic. British Journal of Pharmacology 110(Proceedings Suppl OCT ): 11P

Weber, H.C.; Kramer, M. 1996: VA-Mycorrhiza of Menyanthaceae. Beitraege zur Biologie der Pflanzen 68(3): 351-362

Ansuya, D. 1995: VA-Mycorrhizal A biological tool to control chickpea fusarium wilt. Indian Journal of Mycology and Plant Pathology 25(1-2): 131

Hartnett, D.C.; Hetrick, B.A.D.; Wilson, G.T. 1993: VA-Mycorrhizal influence on competition among co-occurring prairie grasses. Bulletin of the Ecological Society of America 74(2 Suppl): 269

Bratzke, E.C.; Downs, J.B.; Smith, D.B.; Soler, P.M.; Cane, R.D.; Smith, R.A. 1996: VA/Q relationships with varied breathing patterns during one-lung ventilation. Anesthesiology 85(3A): A1158

Hung, M.S.; Wolf, F.; Wightman, B.; Garriga, G.; Way, J.C. 1996: VAB-8 encoding a kinesin-related protein and a coiled-coil protein, is controlling the cell polarity and migration in Caenorhabditis elegans. Molecular Biology of the Cell 7(Suppl ): 409A

Padilla, I.W.; Bover, E.; Basulto, R.; Valderrama, S.; Ramos, M.; Gonzalez, N.; Exposito, M.; Segura, R.; Salazar, E.; Calzada, L.; Hernandez, R.; Serrano, R.; Sanchez, D. 1997: VACOLI Recombinant vaccine against porcine colibacillosis Optimization of the production process and evaluation in field conditions. Biotecnologia Aplicada 14(2): 124-125

Santini, G.; Salvagno, L.; Leoni, P.; Chisesi, T.; Rizzoli, V. 1998: VACOP-B vs VACOP-B + ABMT for aggressive non-Hodgkins lymphoma Results of a prospective randomised trial. British Journal of Haematology 102(1): 152

Santini, G.; Salvagno, L.; Leoni, P.; Chisesi, T.; Congiu, A.M.; Rizzoli, V. 1998: VACOP-B vs VACOP-B plus ABMT for aggressive non-Hodgkins lymphoma Results of a prospective randomised trial. Blood 92(10 Suppl 1 Part 1-2): 465A

Castori, M.; Rinaldi, R.; Capocaccia, P.; Roggini, M.; Grammatico, P. 2008: VACTERL association and maternal diabetes: a possible causal relationship?. Birth Defects Research. Part A Clinical and Molecular Teratology 82(3): 169-172

Wang, H.; Hunter, A.G.; Clifford, B.; McLaughlin, M.; Thompson, D. 1993: VACTERL with hydrocephalus: spontaneous chromosome breakage and rearrangement in a family showing apparent sex-linked recessive inheritance. American Journal of Medical Genetics 47(1): 114-117

Ruzicka, R.M.; Baggot, P.J.; Pallante, V.A.; Seeds, J.W.; Markello, T.C. 1995: VACTERL with hydrocephalus and hemifacial microsomia. American Journal of Human Genetics 57(4 Suppl): A307

Bedini, R.; Chistolini, P.; De Angelis, G.; Formisano, G.; Caiazza, S. 1993: VAD Biomer blood sacs: mechanical tests and ultrastructural observations. Medical Progress Through Technology 19(2): 83-88

Segeren, C.M.; Van Der Holt, B.; Sonneveld, P.; Croockewit, S.; Vellenga, E.; Van Oers, M.H.J.; Richel, D.; Verhoef, G.; Cornelissen, J.J.; Lokhorst, H.M. 1997: VAD administered as intravenous push injection as first-line treatment in stage II/III multiple myeloma. Blood 90(10 Suppl 1 Pt 1): 356A-357A

Lokhorst, H.M.; Sonneveld, P.; Cornelissen, J.J.; Crookewit, S.; Van Der Holt, B.; Van Marwijk Kooy, M.; Van Oers, R.H.J.; Richel, D.; Segeren, C.; Vellenga, E.; Verdonck, L.F.; Verhoef, G.; Wijermans, P.W. 1998: VAD and intermediate-dose melphalan followed by stem cell transplantation in multiple myeloma Results of a phase II and preliminary results of a randomised phase III study. British Journal of Haematology 102(1): 6-7

Weber, D.; Dimopoulos, M.; Sinicrope, F.; Alexanian, R. 1993: VAD-cyclosporin therapy for VAD-resistant myeloma. Blood 82(10 Suppl 1): 581A

Neubauer, M.; Silly, H.; Frudinger, A.; Keil, F. 1992: VAD-regimen to achieve complete remission in patients with multiple myeloma. Annals of Hematology 65(Suppl ): A23

Boissel, J.P.; Cogan Collet, J.; Blondeel, L.; Kaufman, J.M.; Bogaert, M.; Uberla, K.; Dickson, D.; Girard, P.; Tognoni, G.; Lubsen, J. 1992: VALIDATA A comprehensive computerized system to deliver validated information to prescribers. Noothoven van Goor, J , Christensen, J P Studies in Health Technology and Informatics; Advances in medical informatics: Results of the AIM Exploratory Action : 349-357

Semones, S.W.; Young, D.R. 1993: VAM association in a Virginia barrier island population of the actinorhizal shrub, Myrica cerifera. Bulletin of the Ecological Society of America 74(2 Suppl): 433

Sati,S.C.; Pargaien,N. 2008: VAM fungi in some ravine plant roots of Kumaun Himalayan forest. Indian Journal Of Forestry: 1, 103-108

Kemery, R.D. 1993: VAM inoculation of sudex using prairie remnant soil. HortScience 28(5): 192

Olken, S.K.; Corley, R.B. 1998: VAMP-1, VAMP-2 and VAMP-3/cellubrein expression in cells of the B lineage A role in constitutive vesicle trafficking. Molecular Biology of the Cell 9(Suppl ): 207A

Shone, C.; Quinn, C.; Hallis, B.; Fooks, S. 1994: VAMP-2 peptide substrates for botulinum type B neurotoxin. Freer, J, Aitken, R, Alouf, J E, Boulnois, G FEMS Symposium; Bacterial protein toxins 394-395

Martin, L.B.; Shewan, A.M.; Millar, C.A.; Gould, G.W.; James, D.E. 1997: VAMP2 plays a specific role in the insulin-dependent trafficking of GLUT4 in 3T3-L1 adipocytes. Molecular Biology of the Cell 8(Suppl ): 421A

Lapierre, L.A.; Tuma, P.L.; Anderson, J.M. 1997: VAP33 localizes both to an intracellular vesicle fraction and with occludin at the tight junction. Molecular Biology of the Cell 8(Suppl ): 205A

Lapierre, L.A.; Tuma, P.L.; Goldenring, J.R.; Navarre, J.; Anderson, J.M. 1998: VAP33 localizes with occludin at the intercellular tight junction and also with intracellular vesicles. Molecular Biology of the Cell 9(Suppl ): 91A

Gkogkas, C.; Middleton, S.; Kremer, A.M.; Wardrope, C.; Hannah, M.; Gillingwater, T.H.; Skehel, P. 2008: VAPB interacts with and modulates the activity of ATF6. Human Molecular Genetics 17(11): 1517-1526

Mijovic, A.; Singer, J.; Pagliuca, A.; Pagliuca, A.; Mijovic, A.; Hirst, W.; Dobbs, J.; Mufti, G.J. 1994: VAPEC-B An effective therapy for adults with advanced non-Hodgkins lymphoma. British Journal of Haematology 86(Suppl 1): 76

Nickel, W.; Barthel, A.; Tonko, C.; Fuellekrug, J.; Fasshauer, D.; Soeling, H.D. 1994: VAPP14 is involved in the formation of heparan sulfate proteoglycan-carrying secretory vesicles from the trans-Golgi network. Molecular Biology of the Cell 5(Suppl ): 441A

Nalin, D. 1995: VAQTA Hepatitis A vaccine, purified inactivated. Drugs of the Future 20(1): 24-29

Oleinikov, A.V.; Francis, S.E.; Dorfman, J.R.; Rossnagle, E.; Balcaitis, S.; Getz, T.; Avril, M.; Gose, S.; Smith, J.D.; Fried, M.; Duffy, P.E. 2008: VAR2CSA domains expressed in Escherichia coli induce cross-reactive antibodies to native protein. Journal of Infectious Diseases 197(8): 1119-1123

Magistrado, P.; Salanti, A.; Tuikue Ndam, N.G.; Mwakalinga, S.B.; Resende, M.; Dahlbäck, M.; Hviid, L.; Lusingu, J.; Theander, T.G.; Nielsen, M.A. 2008: VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes. Journal of Infectious Diseases 198(7): 1071-1074

Durham, J.S. 1993: VARSKIN Mod 2 A computer code for assessing skin dose. Health Physics 64(Suppl 6): S78-S79

Linial, M.; Levius, O. 1993: VAT-1, an abundant component of Torpedo synaptic vesicle membrane is a calcium binding protein. Society for Neuroscience Abstracts 19(1-3): 1075

Corsello, G.; Maresi, E.; Corrao, A.M.; Dimita, U.; Lo Cascio, M.; Cammarata, M.; Giuffrè, L. 1992: VATER/VACTERL association: clinical variability and expanding phenotype including laryngeal stenosis. American Journal of Medical Genetics 44(6): 813-815

Katzav, S. 1995: Vav: Captain Hook for signal transduction?. Critical Reviews in Oncogenesis 6(2): 87-97

Bustelo, X.R.; Suen, K.L.; Barbacid, M. 1994: VAV interacts with a high molecular weight GTP-binding protein but is not a GDP-releasing factor for ras proteins. Journal of Cellular Biochemistry Suppl 1994(18B): 232

Swadlow, H.A. 1996: VB thalamic afferents have little influence on layer-5 descending corticofugal neurons of rabbit S1 barrel cortex. Society for Neuroscience Abstracts 22(1-3): 18

Swadlow, H.A. 1994: VB thalamic input to putative interneurons of rabbit S-1 Barrel cortex evidence from cross-correlation and microstimulation. Society for Neuroscience Abstracts 20(1-2): 754

Socol, M.L.; Peaceman, A.M. 1998: VBAC An appraisal of fetal risk. American Journal of Obstetrics and Gynecology 178(1 Part 2): S79

Xenakis, E.M.J.; Piper, J.; Mcfarland, M.; Langer, O. 1998: VBAC Predictors of success. American Journal of Obstetrics and Gynecology 178(1 Part 2): S78

Berkus, M.; Langer, O. 1997: VBAC delivery in twin gestation. American Journal of Obstetrics and Gynecology 176(1 Part 2): S135

Fisch, J.; Newman, M.; Feng, T.; Huddleston, J. 1997: VBAC in twin gestations Higher birth weight in twin A is associated with successful trial of labor. American Journal of Obstetrics and Gynecology 176(1 Part 2): S136

Kinkingnéhun, S.; Sarazin, M.; Lehéricy, S.; Guichart-Gomez, E.; Hergueta, T.; Dubois, B. 2008: VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study. Neurology 70(23): 2201-2211

Abraham, C.S.; Vagvolgyi, J.; Tarrade, T.; Koltai, M.; Kovacs, J.; Gellen, B.; Deli, M.A.; Temesvari, P.; Pinter, S.; Braquet, P. 1994: VBN 50727, a hetrazepine-type PAF antagonist, prevents the development of intestinal edema and histopathological changes of necrotizing enterocolitis in newborn piglets A comparison with dexamethasone. Pediatric Research 35(4 Part 2): 210A

Raynor, B.D.; Soylemez, R.; Feng, T.I.; Parthasarathy, S.; Emory, E.K. 1998: VCAM in pregnancy loss. American Journal of Obstetrics and Gynecology 178(1 Part 2): S101

Raynor, B.D.; Soylemez, R.; Feng, T.I.; Parthasarthy, S.; Emory, E.K. 1998: VCAM in preterm labor. American Journal of Obstetrics and Gynecology 178(1 Part 2): S178

Ionescu, C.V.; Rogers, K.A.; Sandig, M. 1998: VCAM-1 and ICAM-1 differentially affect monocyte morphology and transendothelial migration in culture. Molecular Biology of the Cell 9(Suppl ): 86A

Neubauer, K.; Eichhorst, S.T.; Knittel, T.; Fellmer, P.; Ramadori, G. 1996: VCAM-1 and ICAM-1-gene-expression in isolated and cultured rat liver cells. Journal of Hepatology 25(Suppl 1): 114

Ebsworth, K.; Jones, C.; Buckley, G.; Bahra, P.; Lawrence, C.; Williams, R.J. 1998: VCAM-1 and fibronectin provide co-stimulatory signals for IL-4 and IL-5 secretion from human T -cells. Immunology 95(Suppl 1): 79

Gosk, S.; Moos, T.; Gottstein, C.; Bendas, G. 2008: VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. Biochimica et Biophysica Acta 1778(4): 854-863

Akimoto, H.; Mcdonald, T.O.; Weyhrich, J.T.; Thomas, R.; Rothnie, C.; Allen, M.D. 1994: VCAM-1 expression correlates with T-lymphocyte infiltration of cardiac grafts during CD18/ICAM-1 blockade. Circulation 90(4 Part 2): I465

Mathew, C.M.; Dixey, J.; Jones, S.M.; Lovell, C.R.; Mchugh, N.J. 1994: VCAM-1 expression in cutaneous lupus erythematosus versus localized and systemic scleroderma. Arthritis and Rheumatism 37(9 Suppl): S189

Steinbrink, K.; Henseleit, U.; Sunderkoetter, C.; Sorg, C. 1993: VCAM-1 expression in murine cutaneous leishmaniasis and angiogenesis. Journal of Investigative Dermatology 101(3): 420

Wawryk, S.; Jones, D.B. 1993: VCAM-1 expression in reactive and neoplastic lymphoid follicles. Pathology Research and Practice 189(6-7): 840-841

King, T.; Mcdonald, T.O.; Himes, V.E.; Allen, M.D. 1994: VCAM-1 expression is upregulated with CMV infection. Journal of Heart and Lung Transplantation 13(1 Part 2): S34

Toth, M.B.; Marks, R.M.; Smith, E.M.; Richardson, B.C.; Laing, T.J. 1994: VCAM-1 expression on endothelial cells is decreased following treatment with 8-methoxypsoralen and ultraviolet A band light. Clinical Research 42(2): 315A

Mosca, J.D.; Majumdar, M.K.; Mcintosh, K.; Hardy, B.; Moorman, M.; Pittenger, M.F.; Thiede, M.A. 1997: VCAM-1 expression on human mesenchymal stem cells mediates their interaction with mature T-lymphocytes. Blood 90(10 Suppl 1 Pt 2): 174B

Zhang, X.P.; Belland, S.E.; Eisen, H.J. 1998: VCAM-1 gene expression quantified by reverse-transcriptase polymerase chain reaction in endomyocardial biopsies from cardiac transplant recipients predicts subsequent International Heart and Lung Transplant Society Grade 3A rejection. Circulation 98(17): I184

Cayatte, A.J.; Magner, F.; Cohen, R.A. 1997: VCAM-1 induction by TNF-alpha in human umbilical vein endothelial cells A regulatory mechanism sensitive to intracellular generation of reactive oxygen species and exogenous nitric oxide. FASEB Journal 11(3): A457

Duong, L.T.; Tanaka, H.; Rodan, G.A. 1994: VCAM-1 involvement in osteoblast-osteoclast interaction during osteoclast differentiation. Molecular Biology of the Cell 5(Suppl ): 425A

Henseleit, U.; Mahnke, K.; Roth, J.; Sorg, C. 1993: VCAM-1 is increasingly expressed in dermal nerve fibres during murine experimental contact dermatitis. Journal of Investigative Dermatology 101(3): 421

Sasseville, V.; Newman, W.; Lackner, A.; Smith, M.; Lausen, N.; Hesterberg, P.; Beall, D.; Ringler, D. 1992: VCAM-1 is induced and mediates monocyte adhesion to endothelium in SIV encephalitis. Journal of Medical Primatology 21(7-8): 336

Setty, B.N.Y.maja; Dampier, C.D.; Stuart, M.J. 1994: VCAM-1 is involved in mediating hypoxia-induced adherence of sickle red blood cells to endothelium. Pediatric Research 35(4 Part 2): 170A

Gharavi, E.; Pudiak, D.; Looney, R.J. 1993: VCAM-1 on fibroblasts induces TNF-alpha production by monocytes. Arthritis and Rheumatism 36(9 Suppl): S94

Sai, S.; Iwata, A.; Allen, M.D. 1998: VCAM-1 upregulation following mononuclear cell infiltration is linked to embryonic smooth muscle cell phenotype in transplant arteriopathy. FASEB Journal 12(4): A190

Neubauer, K.; Eichhorst, S.T.; Knittel, T.; Fellmer, P.; Ramadori, G. 1996: VCAM-1-gene-expression in isolated rat liver cells and in normal and damaged rat liver. Hepatology 24(4 Part 2): 458A

Dabrowski, M.; Szklarczyk, A.; Nowicka, D.; Kaczmarek, L. 1995: VCAM-I and clathrin heavy chain as possible metrazol induced genes in the rat brain. Acta Neurobiologiae Experimentalis 55(Suppl ): 52

Kalogeris, T.J.; Kevil, C.G.; Coe, L.L.; Phifer, T.J.; Alexander, J.S. 1997: VCAM-dependent monocyte adhesion in human arterial and venous endothelial cells. FASEB Journal 11(3): A302

Van Geuns, Robert J.M.; Wielopolske, Piotr A.; De Bruin, Hein G.; Van Ooijen, Peter M.A.; Oudkerk, Matthijs; Feyter, Pim J. 1998: VCATS Volume coronary angiography using targeted scans, a new strategy in MR coronary angiography. Circulation 98(17): I856-I857

Schroeder, D.T.; Gordon, T.R.; Okamoto, D.; Zuniga, T.L.; Zitter, T.A. 1995: VCG and DNA fingerprint data suggest that Fusarium oxysporum f sp melonis race 1 has recently been introduced into New York State. Phytopathology 85(10): 1173

Lang,G.A.; Lang,R.J. 2008: VCHERRY - an interactive growth, training and fruiting model to simulate sweet cherry tree development, yield and fruit size. Acta Horticulturae 793: 235-242

Margalith, M.; Khatibi, S.; Hobart, P. 1995: VCL1102 A plasmid DNA vector to effect high levels of IL-2 expression in vivo. Journal of Cellular Biochemistry Suppl 1995(21A): 425

Blade, J.; San Miguel, J.F.; Escudero, M.L.; Maldonado, J.; Brunet, S.; Gardella, S.; Alcala, A.; Carnero, M.; Carbonell, F.; Garcia Conde, J.; Besalduch, J.; Marti, J.M.; Ribera, J.M.; Atucha, J.; Fernandez Calvo, J.; Font, L.; Moro, M.J.; Fontanillas, M.; Estap, J.; Montserrat, E. 1996: VCMP/VBAP at standard doses vs VCMP/VBAP at higher doses of cyclophosphamide and doxorubicin as initial treatment of multiple myeloma. Blood 88(10 Suppl 1 Part 1-2): 587A

Samelson, L.E.; Egerton, M.; Ashe, O.R.; Chen, D.; Druker, B.J.; Burgess, W.H. 1993: VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 258

Xu, X.; Colombini, M. 1996: VDAC A channel-forming protein with an auto-directed insertion mechanism. Biophysical Journal 70(2 Part 2): A257

Smidt, M.P.; Wijnholds, J.; Geert, A.B. 1993: VDBP, a liver enriched transcription factor is involved in regulation of the chicken APO-VLDL II gene. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 93

Morgan, S.L.; Teyler, T.J. 1998: VDCC and NMDARs underlie two forms of LTP in CA1 hippocampus in vivo. Society for Neuroscience Abstracts 24(1-2): 1075

Van, D., V., J.S.; Stoop, G.A.; Van, K., F.M. 1995: VDD pacing system. Official Gazette of the United States Patent and Trademark Office Patents 1179(1): 262

Buys, E.M.; Van Hemel, N.M.; Jessurun, E.R.; Kelder, J.C.; Bakema, L.; Kingma, J.H. 1996: VDDR pacing to preserve atrioventricular synchrony for patients after his bundle ablation for paroxysmal atrial fibrillation. European Heart Journal 17(ABSTR Suppl ): 586

Huber, B.E.; Richards, C.A.; Austin, E.A. 1995: VDEPT An enzyme/prodrug gene therapy approach for the treatment of metastatic colorectal cancer. Advanced Drug Delivery Reviews 17(3): 279-292

Wu, G.E.; Larijani, M.; Milijanic, I.; Yu, C.C.K. 1997: VDH and DJH rearrangements in extrachromosomal recombination substrates. Journal of Allergy and Clinical Immunology 99(1 Part 2): S112

Woods, J.W.; Barker, J.; Scott, S.; Singer, I.I. 1994: VDIPEN, a stromelysin-generated aggrecan neo-epitope, is localized in the pericellular matrix of articular cartilage by immuno-EM. Molecular Biology of the Cell 5(Suppl ): 173A

Macro, M.; Le Brun, E.; Cheze, S.; Batho, A.; Reman, O.; Troussard, X.; Leporrier, M. 1998: VDJ rearrangement of immunoglobulin heavy chain genes in 60 patients with multiple myeloma at diagnosis Comparison of two amplification strategies. British Journal of Haematology 102(1): 60-61

Carroll, A. 1995: VDJ recombinase associated signal ends generated in fetal thymic ontogeny. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 7

Sablitzky, F.; Serwe, M. 1993: VDJ recombination in B cells in impaired but not blocked by targeted deletion of the IgH intron enhancer. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 234

Fish, S.M.; Bosma, M.J. 1993: VDJ recombination in mouse thymocytes Age-dependent increase of abnormal deletions in rearranged TCR-delta genes. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 230

Tuaillon, N.; Lonberg, N.; Tucker, P.W.; Capra, J.D. 1994: VDJ recombination mechanisms in a human immunoglobulin transgenic minilocus. FASEB Journal 8(4-5): A467

Guilliams, T.G.; Halligan, B.D. 1994: VDJP A protein capable of immunoglobulin gene recombinational signal sequence directed DNA joining. Journal of Cellular Biochemistry Suppl 1994(18B): 23

Bacci, A.; Machungo, F.; Bugalho, A. 1993: VDRL-positivity and stillbirth in Maputo Central Hospital, Mozambique. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 41(2): 184-185

Haes, D.L.Jr.; Fitzgerald, M.R. 1994: VDT measurement Assessing VDT user dose. Health Physics 66(6 Suppl): S100

Zhang, J.; Liu; Yong; Li; Zhimin 1993: VDT operators occupational stress and psychophysical state. Journal of Xi'an Medical University 14(3): 240-243

Chiang, H. 1993: VDT pulse magnetic field enhances teratogenic effect of ara-c in mice. Zhonghua Yu Fang Yi Xue Za Zhi 27(4): 215-217

Collins, M.; Davis, B.; Atchison, D. 1994: VDT screen reflections and accommodation response. Ophthalmic and Physiological Optics: the Journal of the British College of Ophthalmic Opticians 14(2): 193-198

Lie, I.; Watten, R.G. 1994: VDT work, oculomotor strain, and subjective complaints: an experimental and clinical study. Ergonomics 37(8): 1419-1433

Salmon, E.D. 1995: VE-DIC light microscopy and the discovery of kinesin. Trends in Cell Biology 5(4): 154-158

Müller, A.M.; Gruhn, K.M.; Herwig, M.C.; Tsokos, M. 2008: VE-cadherin and ACE: markers for sepsis in post mortem examination?. Legal Medicine 10(5): 257-263

Guo, M.; Breslin, J.W.; Wu, M.H.; Gottardi, C.J.; Yuan, S.Y. 2008: VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability. American Journal of Physiology. Cell Physiology 294(4): C977-C984

Macaluso, C.; Pavesi, G.; Camparini, M. 1998: VECP from paper? Pattern-onset VECP to a stationary pattern, evoked by the fixation-onset that naturally occurs after saccades. IOVS Investigative Ophthalmology and Visual Science 39(4): S187

Cunningham, D.; Hill, M.E.; Milan, S.; Mansi, J.L.; Smith, I.E.; Catovsky, D.; Gore, M.; O'brien, M.E.R.; Nicolson, M.; Hickish, T. 1994: VEEP chemotherapy for adult Hodgkins disease Assessment of efficacy and gonadal and cardiac toxicity. Blood 84(10 Suppl 1): 162A

Frelin, C.; Ladoux, A.; Bauters, C. 1997: VEGF A mediator of hypoxic angiogenesis. M-S (Medecine Sciences) 13(6-7): 886-890

Lamoreaux, W.J.; Fitzgerald, M.E.C.; Reiner, A.; Hasty, K.A.; Davis, A.A.; Charles, S.T. 1997: VEGF alters gelatinase beta production by human RPE cells in vitro. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S757

Abitbol, M.; Quere, I.; Jambon, P.; Chasse, J.F.; Kobetz, A.; Marchant, D.; Kamoun, P.; Dufier, J.L. 1997: VEGF and KDR gene expression in the human developing eye. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S358

Inuzuka, K.; Hiraki, Y.O.M.; Akagi, Y.; Karayama, T.; Harada, Y.; Konishi, J.; Oda, H.; Hara, Y.; Shirouzi, K. 1996: VEGF and MMP-9 expression in tumor cell induced angiogenesis in colorectal cancer. Clinical and Experimental Metastasis 14(Suppl 1): 100

Li, B.; Sharpe, E.E.; Maupin, A.B.; Teleron, A.A.; Pyle, A.L.; Carmeliet, P.; Young, P.P. 2006: VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 20(9): 1495-1497

Camera, M.; Giessen, P.; Fallon, J.; Taubman, M.; Tremoli, E.; Nemerson, Y. 1995: VEGF and TNF-alpha act synergistically to promote tissue factor synthesis and expression in human umbilical vein endothelial cells. Blood 86(10 Suppl 1): 374A

Toi, M.; Gasparini, G. 1998: VEGF and TP Its clinical implications in human breast cancer. European Journal of Clinical Investigation 28(Suppl 1): A40

Li, J.; Brown, L.F.; Hibberd, M.G.; Grossman, J.D.; Simons, M. 1995: VEGF and VEGF receptors expression in acute myocardial infarction model of angiogenesis. Circulation 92(8): I713

Drevs, J. 2008: VEGF and angiogenesis implications for breast cancer therapy. EJC Suppls 6(6): 7-13

Melder, R.J.; Koenig, G.; Witwer, B.; Safabakhsh, N.; Munn, L.L.; Jain, R.K. 1996: VEGF and bFGF regulate NK cell adhesion to angiogenic vessels through a CD18 and VLA4 dependent mechanism. Proceedings of the American Association for Cancer Research 37: 449

Fiedler, W.; Ergun, S.; Hossfeld, D.K. 1998: VEGF and its receptors in the haemopoietic system. European Journal of Clinical Investigation 28(Suppl 1): A37

Plouet, J.; Jonca, F.; Ortega, N.; Say, J. 1994: VEGF dependent tumoral progression Stimulation by anti VEGF idiotypic antibodies. Journal of Cellular Biochemistry Suppl 1994(18 Part A): 328

Foreman, D.; Williams, G.; Boulton, M.E.; Mcleod, D. 1996: VEGF distribution in proliferative diabetic retinopathy. IOVS Investigative Ophthalmology and Visual Science 37(3): S973

Harding, M.; Herce, M.; Gulding, K.M.; Theodorescu, D. 1998: VEGF enhances tumor development and loss of matrix dependency in human prostate cancer. Journal of Urology 159(5 Suppl): 5

Stragliotto, G.; Tjuvajev, J.; Blasberg, R.G. 1998: VEGF expression in C6, W256 and RG2 cell lines is up-regulated by nutrient depletion , as well as by hypoxia and cobalt chloride. Proceedings of the American Association for Cancer Research 39: 377

Couffinhal, T.; Silver, M.; Witzenbichler, B.; Sheriff, D.D.; Isner, J.M. 1996: VEGF expression in a mouse model of hind limb ischemia. FASEB Journal 10(3): A578

Ortega, N.; Mashhour, B.; Gilet Bazeli, E.; Plouet, J. 1997: VEGF expression in aqueous humor, vitreous and epiretinal membranes in age related macular degeneration. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S358

Hieken, T.J.; Pool, M.; D'allessandro, S.; Kirson, I.; Velasco, J.M. 1997: VEGF expression in pure ductal carcinoma in situ of the breast. Breast Cancer Research and Treatment 46(1): 43

Steinberg, A.P.; Chevrette, M.; Duguid, W.P.; Guy, L.; Tanguay, S. 1998: VEGF expression in renal cell carcinoma. Journal of Urology 159(5 Suppl): 193

Buono, R.J.; Lang, R.K. 1997: VEGF expression in the avascular retina. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S359

Fukumura, D.; Chen, Y.; Gohongi, T.; Seed, B.; Jain, R.K. 1998: VEGF expression in tumors is regulated by oxygen gradient rather than absolute level of hypoxia itself. Proceedings of the American Association for Cancer Research 39: 271

Atala, A.; Soker, S.; Yoo, J.J. 1998: VEGF expression is regulated at the reperfusion phase after renal ischemia. Journal of Urology 159(5 Suppl): 183

Arikawa, T.; Kato, K.; Noguti, T.; Ohara, S.; Sasano, H.; Asaki, S.; Nagura, H.; Toyota, T. 1997: VEGF expression through the healing course of rat experimental gastric ulcer. Gastroenterology 112(4 Suppl): A1129

Hoehn, B.; Harik, S.I.; Hudetz, A.G. 1998: VEGF gene and receptor expression in brain microvessels of adult and neonatal rats. Society for Neuroscience Abstracts 24(1-2): 1170

Pratt, R.E.; Dzau, V.J. 1998: VEGF gene transfer into endothelial cells for vascular prosthesis. Official Gazette of the United States Patent and Trademark Office Patents 1212(4): 3714

Muhlhauser, J.; Merrill, M.J.; Maeda, H.; Bacic, M.; Crystal, R.G.; Capogrossi, M.C. 1994: VEGF gene transfer into vascular smooth muscle and endothelial cells with a replication-deficient recombinant adenovirus vector. Journal of Cellular Biochemistry Suppl 1994(18 Part A): 239

Coppo, R.; Cirina, P.; Peruzzi, L.; Amore, A.; Gianoglio, B.; Porcellini, M.G.; Giraudo, E.; Bussolino, F. 1997: VEGF in IgA nephropathy. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 84A

Kung, W.; Eppenberger Castori, S.; Schlaeppi, J.M. 1996: VEGF in human mammary tumors. Experientia 52(ABSTR ): A32

Kanellis, J.; Mudge, S.J.; Paizis, K.; Kirkland, G.; Power, D.A. 1997: VEGF in rat models of renal disease. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 476A

Lu, M.; Ma, N.; Perez, V.L.; Ding, H.; Allport, J.R.; Luscinskas, F.W.; Adamis, A.P. 1998: VEGF increases retinal vascular ICAM-1 expression and neutrophil adhesion to endothelial cells. IOVS Investigative Ophthalmology and Visual Science 39(4): S580

Coomber, B.L.; Minhas, K. 1997: VEGF induced angiogenesis in vitro shows a biphasic response mediated by matrix proteolysis. FASEB Journal 11(3): A544

Benezra, D.; Maftzir, G. 1998: VEGF induced angiogenesis is inhibited by antibodies against IL-1 or TNFalpha. IOVS Investigative Ophthalmology and Visual Science 39(4): S894

Feng, Y.; Venema, V.J.; Venema, R.C.; Tsai, N.; Caldwell, R.B. 1998: VEGF induces nuclear translocation of its receptor FLK-1, eNOS and caveolin-1. FASEB Journal 12(4): A104

Antonetti, D.A.; Gardner, T.W.; Khin, S.A.; Hollinger, L.A.; Barber, A.J.; Lieth, E. 1998: VEGF induces rapid occludin phosphorylation and ZO-1 translocation in retinal endothelial cells. IOVS Investigative Ophthalmology and Visual Science 39(4): S372

Watanabe, Y.; Dvorak, H.F. 1997: VEGF induces scaffold formation and inhibits apoptosis in microvessel endothelial cells. Cell Structure and Function 22(6): 803

Zucker, S.; Conner, C.; Drews, M.; Lorenz, A.; Tompkins, D.; Jesty, J. 1996: VEGF induction of tissue factor in endothelial cells and conversion of prothrombin to thrombin results in progelatinase A activation and endothelial basement membrane degradation. Clinical and Experimental Metastasis 14(Suppl 1): 103

Bernatchez, P.N.; Soker, S.; Sirois, M.G.G. 1998: VEGF inflammatory and mitogenic effects are Flk-1 dependent. Circulation 98(17): I593

He, H.; Venema, V.J.; Venema, R.C.; Behzadian, M.A.; Caldwell, R.B. 1998: VEGF intracellular signal transduction pathway. IOVS Investigative Ophthalmology and Visual Science 39(4): S919

Dankbar, B.; Padro, T.; Mesters, R.M.; Leo, R.; Ostermann, H.; Serve, H.; Berdel, W.; Kienast, J. 1998: VEGF is expressed by myeloma cells and stimulates IL-6 secretion by microvascular endothelial and marrow stromal cells. Blood 92(10 Suppl 1 Part 1-2): 681A

Kanellis, J.; Mudge, S.J.; Katerelos, M.; Power, D.A. 1998: VEGF is not regulated in renal ischaemia-reperfusion injury but VEGF-R2 is increased and strongly expressed on a tubular cell line. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 579A

Zheng, W.; Tomanek, R.J. 1998: VEGF is upregulated in bradycardia-induced coronary angiogenesis in rat. FASEB Journal 12(4): A71

Lachgar, S.; Charveron, M.; Ceruti, I.; Lagarde, J.M.; Gall, Y.; Bonafe, J.L. 1996: VEGF mRNA expression in different stages of the human hair cycle Analysis by confocal laser microscopy. van Neste, D , Randall, V A International Congress Series; Hair research for the next millenium 407-411

Gavin, T.P.; Specter, D.A.; Wagner, H.; Breen, E.M.; Wagner, P.D. 1998: VEGF mRNA is increased in cardiac muscle immediately following acute exercise. Medicine and Science in Sports and Exercise 30(5 Suppl): S136

Richardson, R.S.; Mudaliar, S.R.D.; Mathieu Costello, O.; Wagner, P.D. 1998: VEGF mRNA response to acute exercise in skeletal muscle is attenuated following chronic training. Medicine and Science in Sports and Exercise 30(5 Suppl): S50

Sasaki, Y.; Kawamoto, A.; Iwano, M.; Kurioka, H.; Takase, E.; Kawata, H.; Tsujimura, S.; Hashimoto, T.; Dohi, K. 1998: VEGF mRNA synthesis by peripheral blood mononuclear cells in acute myocardial infarction. Journal of Molecular and Cellular Cardiology 30(6): A115

Hammer, J.H.; Vangsgaard, K.; Brunner, N.; Nielsen, H.J. 1998: VEGF may be stored as a presynthesized molecule in intracellular granules of leukocytes or platelets. Proceedings of the American Association for Cancer Research 39: 150

Gupta, K.; Kshirsagar, S.; Li, W.; Gui, L.; Ramakrishnan, S.; Gupta, P.; Law, P.Y.; Hebbel, R.P. 1998: VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signalling. Molecular Biology of the Cell 9(Suppl ): 108A

Marko, S.B.; Damon, D.H. 2008: VEGF promotes vascular sympathetic innervation. American Journal of Physiology. Heart and Circulatory Physiology 294(6): H2646-H2652

Spector, D.A.; Breen, E.C.; Wagner, P.D. 1997: VEGF protein levels are increased in the rat gastrocnemius after a single bout of exercise. Medicine and Science in Sports and Exercise 29(5 Suppl): S228

Ryu, J.K.; McLarnon, J.G. 2008: VEGF receptor antagonist Cyclo-VEGi reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult. Journal of Neuroinflammation 5: 18

Carlson, S.G.; Ballermann, B.J. 1996: VEGF receptor expression in glomerular endothelial cells is downregulated by TGF-beta-1. Journal of the American Society of Nephrology 7(9): 1672

Ahmed, A.; Dunk, C. 1997: VEGF receptor suppresses DNA synthesis via trophoblast-derived nitric oxide in first trimester cytotrophoblast-like ED-27 cell line. Placenta 18(5-6): A9

Tufro, A.; Gomez, R.A.iel 1998: VEGF spatially directs angiogenesis in metanephric development in vitro. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 369A

Graham, A.M.; Kishver, Z.; Cooper, D.; Estdale, S.E.; Homer Vanniasinkam, S.; Parkin, S.M. 1998: VEGF stimulation of MAP kinase in human endothelial cells. FASEB Journal 12(4): A166

Pichiule, P.; Chavez, J.C.; Xu, K.; Daugherty, S.; Lamanna, J.C. 1998: VEGF upregulation in global ischemia induced by cardiac arrest and resuscitation in rat brain. Society for Neuroscience Abstracts 24(1-2): 1951

Gabler, C.; Schams, D.; Einspanier, A.; Einspanier, R. 1996: VEGF, TGF-alpha, TGF-beta in the bovine oviduct and indication of their regulation during the estrous cycle. Archiv fuer Tierzucht 39(SPEC ISSUE): 29

Deindl, E.; Ito, W.; Zimmerman, R.J.; Schaper, W. 1998: VEGF, an important angiogenic factor is not involved in arteriogenesis. Journal of Molecular Medicine 76(6): B24

Clausen, M.; El Hifnawi, E.; Hoerauf, H.; Laqua, H. 1997: VEGF, bFGF and TGF-beta-1-3 in macular pucker membranes. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S787

Pieh, C.; Agostini, H.; Buschbeck, C.; Krüger, M.; Schulte-Mönting, J.; Zirrgiebel, U.; Drevs, J.; Lagrèze, W.A. 2008: VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. British Journal of Ophthalmology 92(5): 689-693

Olofsson, B.; Korpelainen, E.; Pepper, M.S.; Mandriota, S.J.; Kumar, V.; Aase, K.; Gunji, Y.; Alitalo, K.; Eriksson, U. 1998: VEGF-B binds to VEGFR-1 and regulates plasminogen activator activity in endothelial cells. Molecular Biology of the Cell 9(Suppl ): 114A

Benest, A.V.; Harper, S.J.; Herttuala, S.Y.; Alitalo, K.; Bates, D.O. 2008: VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis. Cardiovascular Research 78(2): 315-323

Greenwalt, D.E.; Abramian, D.; Leak, L. 1998: VEGF-C upregulation of FLT-4 receptors in Kaposis sarcoma-derived KSY-1 cells. In Vitro Cellular and Developmental Biology. Animal 34(9): 737

Zhang, Q.; Guo, R.; Lu, Y.; Zhao, L.; Zhou, Q.; Schwarz, E.M.; Huang, J.; Chen, D.; Jin, Z.-G.; Boyce, B.F.; Xing, L. 2008: VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism. Journal of Biological Chemistry 283(19): 13491-13499

Thelen, A.; Scholz, A.; Benckert, C.; von Marschall, Z.; Schröder, M.; Wiedenmann, B.; Neuhaus, P.; Rosewicz, S.; Jonas, S. 2008: VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma. International Journal of Cancer 122(11): 2471-2481

Cursiefen, C.; Hofmann Rummelt, C.; Kuechle, M.; Naumann, G.O.H. 1998: VEGF-immunoreactivity in human corneal buttons with neovascularization. IOVS Investigative Ophthalmology and Visual Science 39(4): S743

Sellke, F.W.; Wang, S.Y.; Harada, K.; Lopez, J.J.; Simons, M. 1996: VEGF-induced angiogenesis as an alternate method of revascularization for chronic myocardial ischemia Improved perfusion and vascular reactivity. Journal of the American College of Cardiology 27(2 Suppl A): 92A-93A

Fukumura, D.; Gohongi, T.; Huang, P.L.; Jain, R.K. 1998: VEGF-induced angiogenesis is retarded in type III NOS knockout mice. Proceedings of the American Association for Cancer Research 39: 378

Gabrilovich, D.I.; Oyama, T.; Ran, S.; Ishida, T.; Carbone, D.P. 1997: VEGF-induced blockade of NF-kappa-B function in the abnormal human dendritic cell maturation in cancer. Proceedings of the American Association for Cancer Research 38: 346

Tee, L.B.G.; Penrose, M.A.; O'Shea, J.E.; Lai, C.-M.; Rakoczy, E.P.; Dunlop, S.A. 2008: VEGF-induced choroidal damage in a murine model of retinal neovascularisation. British Journal of Ophthalmology 92(6): 832-838

Deissler, H.; Deissler, H.; Lang, S.; Lang, G.E. 2008: VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells. British Journal of Ophthalmology 92(6): 839-843

Taba, K.E.; Murata, T.; Spee, C.; Cui, J.Z.; Declerck, Y.A.; Hinton, D.R.; Ryan, S.J. 1998: VEGF-induced migration of bovine choroidal endothelial cells inhibited by TIMP-2 and TIMP-2 transduction. IOVS Investigative Ophthalmology and Visual Science 39(4): S721

Tilton, R.G.; Chang, K.; Lejeune, W.; Brock, T.A.; Williamson, J.R. 1998: VEGF-induced vascular permeability and changes in cardiac function are mediated by nitric oxide. FASEB Journal 12(4): A16

Fisseler Eckhoff, A.; Wulf, M.; Gillissen, A.; Mueller, K.M. 1997: VEGF-mRNA expression in squamous cell carcinoma of the lung. Atemwegs- und Lungenkrankheiten 23(8): 468-469

Martiny-Baron, G.; Marmé, D. 1995: VEGF-mediated tumour angiogenesis: a new target for cancer therapy. Current Opinion in Biotechnology 6(6): 675-680

Mei, J.; Gao, Y.; Zhang, L.; Cai, X.; Qian, Z.; Huang, H.; Huang, W. 2008: VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro. Experimental Oncology 30(1): 29-34

Sandner, P.; Wolf, K.; Hammer, M.; Moll, W.; Kurtz, A. 1998: VEGF/VEGF receptor and PDGF/PDGF receptor gene expression in the rat uterus during pregnancy and involution. European Journal of Clinical Investigation 28(Suppl 1): A39

Klagsbrun, M.; Soker, S. 1993: VEGF/VPF: the angiogenesis factor found?. Current Biology: Cb 3(10): 699-702

Watanabe, Y.; Lee, S.W.; Ajioka, I.; Dvorak, H.F. 1996: VEGF/VPF induces escape from senescence in human dermal endothelial cells. Molecular Biology of the Cell 7(Suppl ): 535A

Gardner, T.W.; Khin, S.; Aiello, L.P.; Rook, S.; Barber, A.; Lieth, E. 1997: VEGF/VPF reduces tight junction protein expression in cultured bovine retinal capillary endothelial cells. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S791

Dankbar, B.; Padro, T.; Mesters, R.; Leo, L.; Berdel, W.E.; Kienast, J. 1998: VEGF121/165 is expressed my myeloma cells and stimulates IL-6 secretion by microvascular endothelium in vitro A paracrine growth factor mechanism in multiple myeloma. Annals of Hematology 77(Suppl 2): S113

Ostendorf, T.; Kunter, U.; Janjic, N.; Regele, H.; Kerhaschki, D.; Floege, J. 1998: VEGF165 mediates glomerular endothelial cell proliferation but not proteinuria in immune mediated glomerulonephritis. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 483A

Samuelsson, S.J.; Whitaker, G.B.; Daly, T.J.; Rosenbaum, J.S. 1998: VEGFR-2 expression in endothelial cells as characterized through development of an R-2 specific polyclonal antibody. Molecular Biology of the Cell 9(Suppl ): 113A

Meriggi, F.; Zaniboni, A.; Arcangeli, G.; Alghisi, A.; Marini, G. 1994: VELF An active outpatient regimen for aggressive metastatic breast cancer Preliminary results. European Journal of Cancer 30A(Suppl 1): S22

Field, C.B.; Ruimy, A.; Luo, Y.; Malmström, C.M.; Randerson, J.T.; Thompson, M.V. 1996: VEMAP: model shootout at the sub-continental corral. Trends in Ecology and Evolution 11(8): 313-314

Zulian, G.B.; Mermillod, B.; Iten, P.A.; Miralbell, R.; Guetty Alberto, M.; Helg, C.; Alberto, P. 1996: VEMP An effective first-line chemotherapy combination for Hodgkins Lymphoma allowing safe combination with adjuvant radiotherapy or with high dose chemotherapy and peripheral blood stem cell support in first remission. British Journal of Haematology 93(Suppl 2): 372

Korth, M.; Rix, R.; Sembritzki, Q. 1997: VEP and ERG responses evoked by moving patterns. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S992

Guepratte, N.; Arndt, C.F.; Hache, J.C. 1996: VEP and visual field defect A new approach in multiple sclerosis. IOVS Investigative Ophthalmology and Visual Science 37(3): S1084

Mandel, D.; Zemon, V.; Pinkhasov, E.; Gordon, J.; Mandel, M.; Cook, S. 1996: VEP assessment of neural dysfunction in patients with multiple sclerosis. IOVS Investigative Ophthalmology and Visual Science 37(3): S1086

Westall, C.A.; Buncic, J.R.ymond 1994: VEP contrast sensitivity testing in children with optic nerve glioma. IOVS Investigative Ophthalmology and Visual Science: 35(4)

Iezzi, R.Jr.; Micheli Tzanakou, E. 1993: VEP dependence on 2-D FFT spatial frequency stimulus content. Society for Neuroscience Abstracts 19(1-3): 772

Harrad, R.A.; Norcia, A.M.; Brown, R.J. 1998: VEP dynamics of fusion, binocular rivalry and strabismic suppression. IOVS Investigative Ophthalmology and Visual Science 39(4): S557

Potvin, C.; Braun, C.M.J.; Achim, A. 1994: VEP estimation of interhemispheric relay time. Society for Neuroscience Abstracts 20(1-2): 1002

Kubova, Z.; Kuba, M.; Spekreijse, H. 1995: VEP evidence for predominant parvocellular pathway impairment in retrobulbar neuritis. IOVS Investigative Ophthalmology and Visual Science 36(4): S197

Vigliano, P.; Capizzi, G.; Tornetta, L. 1993: VEP in children with damage of vision. Andermann, F, Beuamanoir, A, Mira, L, Roger, J, Tassinari, C A Mariani Foundation Paediatric Neurology Series; Occipital seizures and epilepsies in children 59-64

Lenassi, E.; Likar, K.; Stirn-Kranjc, B.; Brecelj, J. 2008: VEP maturation and visual acuity in infants and preschool children. Documenta Ophthalmologica. Advances in Ophthalmology 117(2): 111-120

Skoxzenski, A.M.; Norcia, A.M. 1994: VEP measurements of form discrimination in human infants. IOVS Investigative Ophthalmology and Visual Science: 35(4)

Skoczenski, A.M.; Norcia, A.M.; Movshon, J.A. 1996: VEP measures of visual efficiency in human observers. IOVS Investigative Ophthalmology and Visual Science 37(3): S707

Knoblauch, K.; Bieber, M.L.; Werner, J.S. 1994: VEP responses to receptor-isolating stimuli from 8-week-old infants. IOVS Investigative Ophthalmology and Visual Science 35(4): 1571

Lau, C.W.; Klein, S.A.; Carney, T. 1995: VEP source identification using a common time function. IOVS Investigative Ophthalmology and Visual Science 36(4): S692

Tanabe, J.; Kanamori, H.; Matsuzaki, M.; Motomura, S.; Mohri, H.; Okubo, T.; Maruta, A.; Kodama, F. 1994: VEPA and ML-Y1 regimen for elderly non-Hodgkin's lymphoma. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 31(2): 135-141

Suter, P.S.; Brand, P.M.; Eckley, J.D.; Byron, W.L.; Suter, S. 1998: VEPS to words link fixation disparity and reading disability. IOVS Investigative Ophthalmology and Visual Science 39(4): S178

Lytaev, S.; Shevchenko, S. 1997: VEPs and AEPs: mapping of occlusive lesions in cerebral vessels. Annals of the new York Academy of Sciences 821: 524-528

Geer, I.; Westall, C.A.; Eizenman, M. 1994: VEPs in amblyopia Monocular contribution to the binocular response. IOVS Investigative Ophthalmology and Visual Science: 35(4)

Chakraborty, S.; Lehmkuhle, S. 1995: VEPs in awake cats reveal corollary discharge as an early mechanism of saccadic suppression. IOVS Investigative Ophthalmology and Visual Science 36(4): S353

Siegfried, J.B.; Coslett, H.B.; Zemon, V.M. 1995: VEPs indicate an M-pathway deficit in Alzheimers disease patients with visual attention deficits. IOVS Investigative Ophthalmology and Visual Science 36(4): S690

Rudvin, I.; Valberg, A. 1997: VEPs that may separate MC- and PC- pathway inputs to the visual cortex. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S626

Porciatti, V.; Sartucci, F. 1998: VEPs to onset of equiluminant red-green and blue-yellow gratings Normative data. IOVS Investigative Ophthalmology and Visual Science 39(4): S183

Sartucci, F.; Murri, L.; Orsini, C.; Porciatti, V. 1998: VEPs to onset of equiluminant red-green and blue-yellow gratings in multiple sclerosis. IOVS Investigative Ophthalmology and Visual Science 39(4): S184

Kriss, A.; Shawkat, F.S. 1997: VEPs to step changes in contrast from pattern onset/offset to reversal. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S991

Weston, C.F.M.; De Latorre, F.J.; Dick, W.F.; Chamberlain, D.; Bossaert, L. 1998: VEST-CPR system Results of a multicenter randomized pilot study. Journal of the American College of Cardiology 31(2 Suppl A): 403A

Tielsch, J.M.; Steinberg, E.P.; Cassard, S.D.; Schein, O.D.; Javitt, J.C.; Legro, M.W. 1995: VF-14 activity specific outcomes of cataract surgery. IOVS Investigative Ophthalmology and Visual Science 36(4): S841

Anonymous 1974: VG Fesenkov as a geophysicist On his 85th Birthday. Atmospheric and Oceanic Physics 10(1): 63-67

Graff, J.M.; Wolfman, N.; Melton, D.A. 1995: VG1 protein and its receptor Characteristics of a vertebrate embryonic mesoderm inducer. Journal of Investigative Medicine 43(Suppl 2): 209A

Ferri, G.L.; Gaudio, R.M.; Cossu, M.; Rinaldi, A.; Polak, J.M.; Berger, P.; Possenti, R. 1994: VGF gene product in rat pituitary Changes in oestral cycle and after gonadectomy. Society for Neuroscience Abstracts 20(1-2): 97

Hahm, S.; Mizuno, T.; Kelley, K.A.; Mobbs, C.V.; Salton, S.R.J. 1998: VGF knockout mice are hypermetabolic and have the neuroendocrine profile of a fasted mouse. Society for Neuroscience Abstracts 24(1-2): 1120

Hahm, S.; Kelley, K.A.; Salton, S.R.J. 1997: VGF-deficient mice display decreased body size, reduced fertility, nurturing deficits and increased mortality. Society for Neuroscience Abstracts 23(1-2): 2050

De Marchis, S.; Lecomte, M.; Franzoni, M.F.; Maritano, P.; Campantico, E.; Ferri, G.L.; Fasolo, A. 1998: VGF-like immunoreactivity in amphibian hypothalamo-hypophysial system. Annals of the new York Academy of Sciences 839: 442-443

Gitelman, S.E.; Kirk, M.; Kahn, A.J.; Derynck, R. 1993: VGR-1-BMP-6 induces osteogenic differentiation in mesenchymal cells. Pediatric Research 33(5 Suppl): S82

Scott, A.; Alfredson, H.åk.; Forsgren, S. 2008: VGluT2 expression in painful Achilles and patellar tendinosis: evidence of local glutamate release by tenocytes. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 26(5): 685-692

Garcia Ojeda, P.A.; Krasnokutsky, M.V.; Stein, K.E. 1997: VH and V-kappa gene usage in response to Neisseria meningitidis group C polysaccharide. Journal of Allergy and Clinical Immunology 99(1 Part 2): S58

Maloum, K.; Magnac, C.; Azgui, Z.; Charlotte, F.; Cau, C.; Binet, J.L.; Merle Beral, H.; Dighiero, G. 1996: VH gene expression in hairy cell leukemia. Blood 88(10 Suppl 1 Part 1-2): 77A

Scramurra, R.W.; Dahl, L.; Nelson, D.; Ofstehage, J.K.; Janoff, E.N. 1998: VH gene expression in mucosal tissues from seronegative and HIV-1 infected subjects. FASEB Journal 12(5): A886

Maloum, K.; Magnac, C.; Merle Beral, H.; Binet, J.L.; Dighiero, G. 1993: VH gene expression in pre-B lymphoblastic acute leukemia. Nouvelle Revue Francaise d'Hematologie 35(3): 338

Lundkvist, I.; Soderstrom, I.; Feld, S.; Holmberg, D.; Hillorn, V. 1995: VH gene family utilization in patients with autoimmune disease. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 502

Kohsaka, H.; Miyasaka, N.; Rassenti, L.; Chen, P.P.; Kipps, T.J.; Carson, D.A. 1995: VH gene repertoires of peripheral IgM and IgG B cells from rheumatoid arthritis monozygotic twins. Arthritis and Rheumatism 38(9 Suppl): S373

Cooperstone, B.G.; Ohliger, M.; Madaio, M.P.; Foster, M.H. 1993: VH gene restriction limited to mesangial immune deposit forming anti-DNA antibodies. Journal of the American Society of Nephrology 4(3): 597

Pritsch, O.; Troussard, X.; Magnac, C.; Davi, F.; Mauro, F.; Pulik, M.; Macro, M.; Dumas, G.; Schroeder, H.W.Jr.; Leporrier, M.; Dighiero, G. 1998: VH gene usage by family members affected with chronic lymphocytic leukemia. Blood 92(10 Suppl 1 Part 1-2): 268B

Chang, Q.; Abadi, J.; Pirofski, L. 1998: VH gene usage in healthy adults after vaccination with a 23-valent pneumococcal polysaccharide vaccine. Abstracts of the General Meeting of the American Society for Microbiology 98: 241

Maloum, K.; Davy, F.; Magnac, C.; Pritsch, O.; Mcintyre, E.; Binet, J.L.; Merle Beral, H.; Dighiero, G. 1994: VH nucleotide sequence in 12 cases of CD5 negative B-CLL. Blood 84(10 Suppl 1): 455A

Pinchuk, G.V.; Alexander, C.M.; Armitage, R.J.; Milner, E.B. 1996: VH repertoire of human B cells activated by CD40 ligand and IL-4. FASEB Journal 10(6): A1165

Stewart, A.K.; Huang, C.; Long, A.A.; Stollar, B.D.; Schwartz, R.S. 1992: VH-gene representation in autoantibodies reflects the normal human B-cell repertoire. Immunological Reviews 128: 101-122

Hansen, A.; Jahn, S.; Von Baehr, R.; Settmacher, U. 1992: VH/VL gene analysis of human hybridomas from the fetal B cell repertoire. Immunobiology 186(1-2): 21

Townsley Fuchs, J.; Goodglick, L.; Valles Ayoub, Y.; Braun, J. 1994: VH3 immunoglobulin of the natural antibody repertoire compete for the CD4 binding site of GP120 and neutralize HIV infection. FASEB Journal 8(4-5): A493

Townsley Fuchs, J.; Goodglick, L.; Braun, J. 1995: VH3 immunoglobulins of the natural antibody repertoire bind gp120, activate complement and sequester gp120 away from T-cells. Journal of Cellular Biochemistry Suppl 1995(21B): 227

Egan, M.; Mccabe, R.P.; Peters, M. 1994: VH4 immunoglobulin region usage in normal intestinal B lymphocytes. Gastroenterology 106(4 Suppl): A676

Egan, M.; Mccabe, R.P.; Carroll, W.L.; Peters, M.G. 1993: VH4 immunoglobulin variable region usage in intestinal B lymphocytes from patients with Crohns disease. Gastroenterology 104(4 Suppl): A695

Powell, M.J.; Bieber, M.; Teng, N.; Van Vollenhoven, R.F. 1997: VH4-34 antibody is marker for systemic lupus erythematosus and correlates with disease severity. Arthritis and Rheumatism 40(9 Suppl): S207

Funkhouser, W.K.; Hsu, F.; Levy, R.; Warnke, R.A. 1997: VH421 gene segment utilization in human lymphomas. Laboratory Investigation 76(1): 125A

Chen, X.; Kearney, J.F. 1993: VH81X-encoded IgM transgenic mice. Journal of Immunology 150(8 Part 2): 253A

Cairns, E.; Keet, M.; Edwards, J.Y.; Bell, D.A. 1997: VHCDR3 regions is SLE and normal IgG B cells. Arthritis and Rheumatism 40(9 Suppl): S134

Ehnholm, G.J. 1996: VHF applicator for magnetic resonance imaging. Official Gazette of the United States Patent and Trademark Office Patents 1191(3): 1610

Hmila, I.; Abdallah R, B.Abderrazek-Ben.; Saerens, D.; Benlasfar, Z.; Conrath, K.; Ayeb, M.El.; Muyldermans, S.; Bouhaouala-Zahar, B. 2008: VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'. Molecular Immunology 45(14): 3847-3856

Brauch, H.; Zbar, B.; Neumann, H.P.H. 1996: VHL disease with pheochromocytoma in the Black Forest is caused by a T fwdarw C change at nucleotide 505 of the VHL gene which was introduced by a common ancestor. Mueller, H Author, Scott, R Journal Author, Weber, W Author Hereditary cancer : 126-128

Vortmeyer, A.O.; Lubensky, I.A.; Khettry, U.; Fogt, F.; Linehan, W.M.; Zhuang, Z. 1997: VHL gene alterations detected in microcystic adenomas of the pancreas. Laboratory Investigation 76(1): 148A

Kim, W.Y.; Sharpless, N.E. 2008: VHL inactivation: a new road to senescence. Cancer Cell 13(4): 295-297

Mikhaylenko, D.S.; Kurynin, R.V.; Popov, A.M.; Karyakin, O.B.; Enikeev, M.E.; Alyaev, Y.G.; Nemtsova, M.V.; Zaletayev, D.V. 2008: VHL inactivation in sporadic clear cell renal carcinoma. Molecular Biology 42(1): 64-69

Latif, F.; Yao, M.; Tory, K.; Glenn, G.; Maher, E.; Linehan, W.M.; Zbar, B.; Lerman, M.I. 1992: VHL is located close to D3S601 in the interval between RAF1 and D3S18. American Journal of Human Genetics 51(4 Suppl): A63

Ivanov, S.V.; Kuzmin, I.; Wei, M.H.; Karavanova, I.D.; Perantoni, A.O.; Pack, S.; Geil, L.; Stanbridge, E.; Lerman, M.I. 1998: VHL target genes Identification of eight genes, involved in growth, development, and carcinogenesis. Proceedings of the American Association for Cancer Research 39: 558

Anath, S.; Jiang, L.; Knebelmann, B.; Gruning, W.; Stuart Tilley, A.K.; Alper, S.L.; Sukhatme, V.P. 1998: VHL tumor suppressor regulates AE-2 and NHE-3 mRNA levels and corresponding ion exchange activities in renal carcinoma cells. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 386A

Hallauer, J. 1995: VHPB Summary of strategies and recommendations. Vaccine 13(Suppl 1): S61-S63

Saedi, M.S.; Guido, E.; Knott, C.; Kuus Reichel, K.; Kumar, A. 1996: VHR dual-specificity phosphatase partially suppresses the ras-induced transformation of Rat-1 cells. Proceedings of the American Association for Cancer Research 37: 504

Snow,M.; Gregory,A. 2008: VHSV - risks to aquaculture?. Fish Farmer: 3, 58-59

D.G.est, M.R.; Norre, M.E. 1995: VHT-test battery and posturography compared in the follow-up of patients with BPPV. Claussen, C -F, Sakata, E, Itoh, A International Congress Series; Vertigo, nausea, tinnitus and hearing loss in central and peripheral vestibular diseases 185-188

Ohtsuka, S.; Sugishita, Y. 1998: VI Analyses of biological samples using synchrotron radiation 5 Cardiovascular imaging by using synchrotron radiation. Radioisotopes 47(12): 976-981

Schilling, F.; Spindler Thiele, S. 1998: VI Psoriatic enthesopathy as a morphological element of SAPHO syndrome and its relation to ossifying periostitis. Aktuelle Rheumatologie 23(Suppl 1): S55-S58

Rwiza, H.T. 1994: VI The Muhimbili epilepsy project, a three pronged approach Assessment of the size of the problem, organization of an epilepsy care system and research on risk factors. Tropical and Geographical Medicine 46(3 Suppl): S22-S24

Ritter, M.A.; George, A.J.T. 1997: VI form summer schools The Hammersmith experience. Immunology 92(Suppl 1): 1

Cruz Neira, C.; Defanti, T.A.; Langley, R.; Stevens, R.; Bash, P.A. 1995: VIBE A virtual biomolecular environment for interactive molecular modeling. Biophysical Journal 68(2 Part 2): A345

Glasmacher, A.; Gieseler, F.; Gorschlueter, M.; Goldschmidt, H.; Maintz, C.; Mezger, J.; Heyll, A.; Haferlach, T.; Clemens, M.; Ko, Y.; Derichs, R. 1998: VID in the treatment of refractory and de novo multiple myeloma. Annals of Hematology 77(Suppl 2): S183

Pierre, P.; Tarte, K.; Fabbro, M.; Legouffe, E.; Lavabre Bertrand, T.; Navarro, M.; Gris, J.C.; Jorgensen, C.; Sany, J.; Rossi, J.F. 1994: VID program associating etoposide , ifosfamide and dexamethasone A pilot study for multiple myeloma. Blood 84(10 Suppl 1): 658A

Cotto, E.; Rivera, M. 1997: Vidisa. Diabetologia 40(Suppl 1): A608

Miksch, S.; Horn, W.; Popow, C.; Paky, F. 1993: VIE-VENT Knowledge-based monitoring and therapy planning of the artificial ventilation of newborn infants. Andreassen, S , Engelbrecht, R , Wyatt, J Studies in Health Technology and Informatics; Artificial intelligence in medicine 218-229

Danesi, M.A. 1994: VII Epilepsy and the secondary schools in Nigeria. Tropical and Geographical Medicine 46(3 Suppl): S25-S27

Anonymous 1996: VII National morphological contest of select pigs EXPOAVIGA 95. Avances En Alimentacion Y Mejora Animal 36(1): 26-27

Bertolote, J.M. 1994: VIII Epilepsy as a public health problem Role of the World Health Organization and of the cooperation between WHO and non-governmental organizations. Tropical and Geographical Medicine 46(3 Suppl): S28-S30

Kamnert, I.; Liao, C.; Lopez, C.C.; Rosen, M.; Edstrom, J.E.ik 1997: VIII International Balbiani Ring Workshop. Hereditas (Lund) 127(3): 265-286

International Workshop, O.Gastro Duodenal Pathology And \$helicobacter \$pylori 1995: VIIIth International Workshop on Gastro-duodenal Pathology and Helicobacter pylori, Edinburgh, Scotland, UK, July 7-9, 1995. Gut 37(Suppl 1): A1-A97

Bosque, C.; Escalante, P. 2008: VIIIth Neotropical Ornithological Congress, Maturin, Venezuela, 13-19 de Mayo de 2007 Informe del Secretario General y de la Presidenta. Ornitologia Neotropical 19(Suppl S): 1-32

Chadburn, A.; Hyjek, E.; Ying, L.; Knowles, D.M.; Cesarman, E. 1998: VIL-6 expression correlates with development of Kaposis sarcoma and survival in HIV-infected individuals. Blood 92(10 Suppl 1 Part 1-2): 302A

Braunwell, K.H.; Lenz, S.E.; Gundelfinger, E.D. 1995: VILIP - A member of the new family of neuronal Ca-2+-binding proteins Interaction with intracellular binding partners and possible function in vivo. Journal of Neurochemistry 65(Suppl ): S143

Braunewell, K.H.; Wetzel, W.; Gundelfinger, E.D. 1996: VILIP A member of a family of neuronal calcium-binding proteins Functional studies in transfected cells. Society for Neuroscience Abstracts 22(1-3): 260

Braunewell, K.H.; Lenz, S.E.; Gundelfinger, E.D. 1995: VILIP A neuronal calcium-binding protein Interaction with intracellular target molecules and possible involvement in neuronal differentiation. Biological Chemistry Hoppe-Seyler 376(SPEC Suppl ): S87

Spilker, C.; Gundelfinger, E.D.; Braunewell, K.H. 1997: VILIP A neuronal calcium-sensor protein Effect of myristoylation on cellular localization and functional activity. European Journal of Cell Biology 72(Suppl 43): 33

Braunewell, K.H.; Lenz, S.E.; Gundelfinger, E.D. 1995: VILIP-a member of a new sub-family of neuronal Ca-2+-binding proteins Interaction with intracellular target molecules and expression in neuronal cells. Biological Chemistry Hoppe-Seyler. 376(spec. Suppl): S87

Schneider, I.; Keuleyan, E.; Rasshofer, R.; Markovska, R.; Queenan, A.Marie.; Bauernfeind, A. 2008: VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany. Antimicrobial Agents and ChemoTherapy 52(8): 2977-2979

Moody, T.W.; Leyton, J.; Eckelman, W.; Lang, L.; Clark, G.; Gozes, I.; Mantey, S.; Jensen, R.T. 1997: VIP agonists and breast cancer. Regulatory Peptides 71(2): 123

Hill, J.M.; DibbernD.A.Jr.; Gozes, I.; Fridkin, M.; Brenneman, D.E. 1995: VIP analogues stimulates embryonic growth through GTP-insensitive binding sites. Society for Neuroscience Abstracts 21(1-3): 1783

Zamostiano, R.; Bassan, M.; Giladi, E.; Davidson, A.; Wollman, Y.; Pitman, J.; Hauser, J.; Gibney, G.; Castellon, R.; Brenneman, D.E.; Gozes, I. 1998: VIP and ADNF-9 influence intracellular and extracellular heat shock proteins. Society for Neuroscience Abstracts 24(1-2): 1044

Zhou, L.; Mcgivern, R.F. 1995: VIP and AVP mRNA expression in the suprachiasmatic nucleus of the rat brain following shock stress. Society for Neuroscience Abstracts 21(1-3): 1948

Kagstrom, J.; Holmgren, S. 1997: VIP and CGRP relax small arteries via distinct mechanisms in the rainbow trout, Oncorhynchus mykiss. Journal of the Autonomic Nervous System 65(2-3): 90

Moody, T.W.; Jakowlew, S.; Chung, P.; Fridkin, M.; Gozes, I. 1994: VIP and PACAP bind with high affinity to human glioblastoma cells. Society for Neuroscience Abstracts 20(1-2): 1347

Magistretti, P.J.; Martin, J.L. 1997: VIP and PACAP in the CNS Modulators of synaptic transmission and mediators of neuron glia communication. Regulatory Peptides 71(2): 121

Bredow, S.; Kacsoh, B.; ObalFerenc, J.; Krueger, J.M. 1994: VIP and PACAP induce PRL mRNA expression in rat hypothalamus. Journal of Sleep Research 3(Suppl 1): 32

Delgado, M. 1998: VIP and PACAP inhibit endotoxin-induced TNFa production by macrophages. Journal of Neuroimmunology 90(1): 39

Delgado, M.; Pozo, D.; Martinez, C.; Gomariz, R.P.; Ganea, D. 1998: VIP and PACAP inhibit endotoxin-induced TNFa production in macrophages. Journal of Neuroimmunology 90(1): 62

Martin, J.L.; Gasser, D.; Magistretti, P.J. 1995: VIP and PACAP potentiate c-fos expression induced by glutamate in cultured cortical neurons. Experientia 51(ABSTR ): A81

Stella, N.; Magistretti, P.J. 1995: VIP and PACAP potentiate the glutamate-evoked release of arachidonic acid from mouse cortical neurons. Society for Neuroscience Abstracts 21(1-3): 1376

Waschek, J.A. 1996: VIP and PACAP receptor-mediated actions on cell proliferation and survival. Annals of the new York Academy of Sciences 805: 290-300; Discussion: 300-301

Martin, J.L.; Magistretti, P.J.; Pellegri, G. 1996: VIP and PACAP stimulate BDNF expression by potentiating the effect of glutamate. Society for Neuroscience Abstracts 22(1-3): 545

Smith, J.A.; Sayer, J.M.; Coupland, K.; Long, R.G. 1994: VIP and PACAP stimulated adenylate cyclase activity is not inhibited by the VIP antagonist VIP in human duodenum. Gastroenterology 106(4 Suppl): A842

Ganea, D.; Sun, L.; Xin, Z.; Tang, H. 1995: VIP and PACAP, two structurally related neuropeptides downregulate production of IL-2 and IL-4 in murine lymphocytes. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 417

Ganea, D.; Martinez, C.; Delgado, M.; Sun, W.; Gomariz, R.P. 1996: VIP and PACAP-38 inhibit IL-10 production in murine T lymphocytes. FASEB Journal 10(6): A1073

Wiik, P.; Skrede, K.K.; Knardahl, S.; Aero, C.E.; Haugen, A.H.; Roshoel, H.; Haugen, S.; Boyum, A. 1995: VIP and beta-Adrenergic inhibition of rat peritoneal monocyte chemiluminescence ex vivo Modulation by fasting, corticosterone administration in vivo, and adrenalectomy. Regional Immunology 6(5-6): 428-432

Olah, Z.; Lehel, C.; Brenneman, D.E.; Buonanno, A.; Anderson, W.B.; Agoston, D.V. 1992: VIP and forskolin induces nuclear translocation of PKC isoenzymes in rat cortical astrocytes. Society for Neuroscience Abstracts 18(1-2): 65

Sorg, O.; Stolz, M.; Beggah, S.; Magistretti, P.J. 1992: VIP and noradrenaline exert a long-term control in glycogen levels in astrocytes Blockade by protein synthesis inhibition. Society for Neuroscience Abstracts 18(1-2): 785

Nguyen, T.D.; Fox, N.R. 1995: VIP and secretin receptors Characterization of structure-function relationship using chimeric receptors. Gastroenterology 108(4 Suppl): A994

Xu, K.P.; Shinozaki, N.; Tsubota, K. 1994: VIP and substance P in lacrimal glands of Sjogrens syndrome. IOVS Investigative Ophthalmology and Visual Science 35(4): 1793

Arranz, A.; Juarranz, Y.; Leceta, J.; Gomariz, R.P.; Martínez, C. 2008: VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4. Peptides 29(6): 948-956

Chakder, S.; Rattan, S. 1994: VIP binding sites in internal anal sphincter smooth muscle cells and myenteric neuronal membranes. Gastroenterology 106(4 Suppl): A475

Cacicedo, L.; Navarro, C.; Sanchez Franco, F. 1997: VIP blockade reduces proliferation of human NB-69 neuroblastoma cells. Society for Neuroscience Abstracts 23(1-2): 2447

Dickman, K.; De Stefanis, P.; Said, S.I. 1997: VIP directly attenuates central neuronal excitotoxicity. Society for Neuroscience Abstracts 23(1-2): 2300

Kohlmeier, K.A.; Reiner, P.B. 1998: VIP effects on medial pontine reticular formation neurons within the REM-induction zone. Society for Neuroscience Abstracts 24(1-2): 1429

Pakbaz, H.; Berisha, H.; Sharaf, H.; Foda, H.D.; Said, S.I. 1994: VIP enhances and nitric oxide synthase inhibitor reduces survival of rat lungs perfused ex vivo. Annals of the new York Academy of Sciences 723: 426-428

Pincus, D.W.; Lu, N.; Black, I.B.; Dicicco Bloom, E. 1993: VIP exerts both mitogenic and trophic effects on sympathetic neuroblast proliferation. Society for Neuroscience Abstracts 19(1-3): 869

Gozes, I.; Glowa, J.; Brenneman, D.E.; Mccune, S.K.; Lee, E.; Westphal, H. 1993: VIP function assessed by molecular genetic techniques. Journal of Neurochemistry 61(Suppl ): S86

Bandyopadhyay, A.; Chakder, S.; Rattan, S. 1993: VIP gene expression is characteristically rich in gastrointestinal sphincters. Gastroenterology 104(4 Suppl): A811

Glazer, R.; Ticher, A.; Ashkenazi, I.E.; Fridkin, M.; Brenneman, D.E.; Gozes, I. 1993: VIP gene expression is involved in the determination of biological rhythms. Society for Neuroscience Abstracts 19(1-3): 572

Jakowlew, S.; Gozes, Y.; Fridkin, M.; Gozes, I.; Moody, T.W. 1995: VIP hybrid A peptide receptor antagonist which inhibits breast cancer growth. Proceedings of the American Association for Cancer Research 36: 256

Schaad, N.C.; Vanecek, J.; Klein, D.C.; Russell, J.T. 1992: VIP increases intracellular calcium concentration in rat pinealocytes by increasing permeability across the plasma membrane. Society for Neuroscience Abstracts 18(1-2): 989

Ameen, N.; Martensson, B.A.; Koss, M.; Belayev, L.; Bourguignon, L.; Isenberg, J. 1997: VIP induces increased apical expression for CFTR in proximal small intestinal villus cells in vivo. Gastroenterology 112(4 Suppl): A345

Bardea, A.; Glazer, R.; Liling, G.; Gozes, I. 1992: VIP influences electrophysiological and metabolic activities in vivo. Society for Neuroscience Abstracts 18(1-2): 989

Zhu, Y.; Ikeda, Stephen, R. 1994: VIP inhibits N-type Ca-2+ channels of sympathetic neurons via a G-s-alpha-dependent pathway. Society for Neuroscience Abstracts 20(1-2): 902

Louis Jacques, O.; Gilmont, R.; Sladick, J.; Bitar, K.N. 1996: VIP inhibits bombesin induced phosphorylation and translocation of HSP27 during smooth muscle contraction in rabbit colon. Gastroenterology 110(4 Suppl): A709

Louis Jacques, O.; Yamada, H.; Sladick, J.; Bitar, K.N. 1996: VIP inhibits contraction mediated by RAF-MAP kinase kinase activation of MAP kinase in isolated smooth muscle cells from rabbit colon. Gastroenterology 110(4 Suppl): A710

Wadwa, K.S.; Kuo, W.H.; Ferris, C.F.; Schwartz, G.J.; Snyder, S.H.; Pasricha, P.J. 1997: VIP inhibits gastric emptying in wild type mice but not in mice lacking neuronal NOS. Gastroenterology 112(4 Suppl): A848

Maruno, K.; Said, S.I. 1996: VIP inhibits the proliferation of small-cell and nonsmall-cell lung carcinoma. Annals of the new York Academy of Sciences 805: 389-392; Discussion: 392-393

Cho, W.K.; Mennone, A.; Rydberg, S.A.; Boyer, J.L. 1995: VIP is a potent stimulus of bicarbonate and fluid secretion in bile ducts. Hepatology 22(4 Part 2): 294A

Holle, G.E.; Wuensch, E. 1995: VIP is the main inhibitory neurotransmitter of the external muscle coat in the gastro-duodenal region. Gastroenterology 108(4 Suppl): A615

Mccune, S.K.; Hayek, B.; Summers, R.W. 1996: VIP mRNA expression in the gut after irradiation injury. Pediatric Research 39(4 Part 2): 123A

Matthew, J.D.; Wadsworth, R.M. 1994: VIP may contribute to neurogenic relaxation in the sheep middle cerebral artery. British Journal of Pharmacology 111(Proceedings Suppl JAN ): 266P

Gurantz, D.; Harootunian, A.T.; Tsien, R.Y.; Dionne, V.E.; Margiotta, J.F. 1994: VIP modulates neuronal nicotinic acetylcholine receptor function by a cyclic AMP-dependent mechanism. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 14(6): 3540-3547

Wong, H. 1996: VIP monoclonal antibody. Hybridoma 15(2): 164

Magistretti, P.J.; Pellerin, L.; De Rham, S.; Sorg, O.; Martin, J.L. 1994: VIP neurons exert homeostatic functions within the cerebral cortex by interacting with non-neuronal cells. Neuropeptides 26(Suppl 1): 43-44

Said, S.I.; Raza, S.; Berisha, H.I. 1997: VIP protects against vascular effects of beta-amyloid peptide. Regulatory Peptides 71(2): 132

Moody, T.W.; Leyton, J.; Gozes, I.; Fridkin, M.; Takahashi, K.; Jameison, F.; Koh, M.; Knight, M. 1997: VIP receptor antagonists inhibit the growth of glioblastoma cells. Society for Neuroscience Abstracts 23(1-2): 2239

Hill, J.M.; Mccune, S.K. 1992: VIP receptor distribution is related to ontogenetic events in the developing cortex, hippocampus and cerebellum. Society for Neuroscience Abstracts 18(1-2): 1294

Nguyen, T.D.; Fox, N.R.; Heintz, G.G.; Greene, R. 1994: VIP receptors on rat liver plasma membranes differ from those expressed using the VIP receptor gene from rat lung. Gastroenterology 106(4 Suppl): A829

Hill, J.M.; McCune, S.K.; Alvero, R.J.; Glazner, G.W.; Brenneman, D.E. 1996: VIP regulation of embryonic growth. Annals of the new York Academy of Sciences 805: 259-268; Discussion: 268-269

Arranz, A.; Gutiérrez-Cañas, I.; Carrión, M.; Juarranz, Y.; Pablos, J.é L.; Martínez, C.; Gomariz, R.P. 2008: VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts. Molecular Immunology 45(11): 3065-3073

Rekik, M.; Delvaux, M.; Frexinos, J.; Bueno, L. 1995: VIP sequentially triggers adenylate cyclase and synthesis of nitric oxide to relaxed isolated smooth muscle cells from guinea-pig ileum. Gastroenterology 108(4 Suppl): A677

Cho, W.K.; Boyer, J.L. 1997: VIP stimulates bile secretion in cholangiocytes by cAMP-, PKA-independent mechanisms. Hepatology 26(4 Part 2): 397A

D.G.rolamo, P.; Arcamone, N.; Esposito, V.; Battaglini, P.; Gargiulo, G. 1995: VIP, ANF and Met-enk-immunoreactive cells in the gills of Poecilia latipinna adapted to different salinities. Acta Anatomica 152(4): 275

Cardinaux, J.R.; Magistretti, P.J. 1996: VIP, PACAP, and noradrenaline induce the transcription factors C/EPB-beta and C/EBP-delta in mouse cortical astrocytes; Involvement in cAMP-regulated glycogen metabolism. Experientia 52(ABSTR ): A59

Gourlet, P.; Vandermeers, A.; De Neef, P.; Cnudde, J.; Waelbroeck, M.; Robberecht, P. 1997: VIP, helodermin and PACAP analogues discriminate rat and human VIP1 and VIP2 receptors. Regulatory Peptides 71(2): 149

Basiboina, R.; Hale, C.; Haycock, J.W.; Strong, R. 1992: VIP, secretin, and PACAP act at distinct receptors to increase tyrosine hydroxylase gene expression in PC12 cells. Society for Neuroscience Abstracts 18(1-2): 1377

Luts, L.; Bergenfelz, A.; Alumets, J.; Luts, A.; Sundler, F. 1996: VIP- and PACAP-containing nerve fibers in human parathyroid glands and adenomas: comparison of innervation pattern with animal species. Annals of the new York Academy of Sciences 805: 661-665

Dupree, P.; Parton, R.; Kurzchalia, T.V.; Simons, K. 1992: VIP-21, an integral component of trans-Golgi-network-derived transport vesicles. Molecular Biology of the Cell 3(Suppl ): 308A

Petit, J.M.; Luppi, P.H.; Fort, P.; Jouvet, M. 1994: VIP-LI projections from the midbrain raphe nuclei to the rat bed nucleus of the stria terminalis. Society for Neuroscience Abstracts 20(1-2): 514